{
    "id": "dbpedia_2406_0",
    "rank": 49,
    "data": {
        "url": "https://www.ohsu.edu/alzheimers-disease-research-center/research-publications",
        "read_more_link": "",
        "language": "en",
        "title": "Research Publications",
        "top_image": "https://www.ohsu.edu/themes/custom/ohsu_digs/favicon.ico",
        "meta_img": "https://www.ohsu.edu/themes/custom/ohsu_digs/favicon.ico",
        "images": [
            "https://www.ohsu.edu/sites/default/files/2024-03/2017_0920_SHARP_009_500x346_1.jpg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Publications authored by researchers at the OHSU Layton Aging and Alzheimer's Disease Research Center.",
        "meta_lang": "en",
        "meta_favicon": "/themes/custom/ohsu_digs/favicon.ico",
        "meta_site_name": "",
        "canonical_link": "https://www.ohsu.edu/alzheimers-disease-research-center/research-publications",
        "text": "Alatrany AS, Khan W, Hussain A, Kolivand H, Al-Jumeily D. An explainable machine learning approach for Alzheimer's disease classification. Sci Rep. 2024 Feb 1;14(1):2637. doi: 10.1038/s41598-024-51985-w. PMID: 38302557; PMCID: PMC10834965.\n\nAlcázar Magaña A, Vaswani A, Brown KS, Jiang Y, Alam MN, Caruso M, Lak P, Cheong P, Gray NE, Quinn JF, Soumyanath A, Stevens JF, Maier CS. Integrating High-Resolution Mass Spectral Data, Bioassays and Computational Models to Annotate Bioactives in Botanical Extracts: Case Study Analysis of C. asiatica Extract Associates Dicaffeoylquinic Acids with Protection against Amyloid-β Toxicity. Molecules. 2024 Feb 13;29(4):838. doi: 10.3390/molecules29040838. PMID: 38398590; PMCID: PMC10892090.\n\nAppleman M, Nilaver B, Weiss A, Kohama S, Urbanski H. Effect of hormone replacement therapy on amyloid beta (Aβ) plaque density in the rhesus macaque amygdala. Frontiers in Aging Neuroscience 15:1326747, 2024. PMC10808750. DOI: 10.3389/fnagi.2023.1326747\n\nCervera-Juanes R, Zimmerman KD, Wilhelm L, Zhu D, Bodie J, Kohama SG, Urbanski HF. Modulation of neural gene networks by estradiol in old rhesus macaque females. bioRxiv [Preprint]. 2023 Dec 18:2023.12.18.572105. doi: 10.1101/2023.12.18.572105. PMID: 38187564; PMCID: PMC10769303.\n\nCho Y, Iliff JJ, Lim MM, Raskind M, Peskind E. A case of prazosin in treatment of rapid eye movement sleep behavior disorder. J Clin Sleep Med. 2024 Feb 1;20(2):319-321. doi: 10.5664/jcsm.10888. PMID: 37882640; PMCID: PMC10835776.\n\nChoudhury P, Lee-Iannotti JK, Busicescu AO, Rangan P, Fantini ML, Avidan AY, Bliwise DL, Criswell SR, During EH, Elliott JE, Fields JA, Gagnon JF, Howell MJ, Huddleston DE, McLeland J, Mignot E, Miglis MG, Lim MM, Pelletier A, Schenck CH, Shprecher D, St Louis EK, Videnovic A, Ju YS, Boeve BF, Postuma R. Validation of the RBD Symptom Severity Scale in the North American Prodromal Synucleinopathy Consortium. Neurology 102:e208008, 2024. DOI: 10.1212/WNL.0000000000208008\n\nCroff R, Aron S, Wachana A, Fuller P, Mattek N, Towns J, Kaye J. Walking and Social Reminiscence in Gentrifying Neighborhoods: Feasibility and Impact on Cognitive, Physical, and Mental Health Among Older Black Adults in the SHARP Study. Gerontologist. 2024 Feb 27:gnae019. doi: 10.1093/geront/gnae019. Epub ahead of print. PMID: 38412543.\n\nDuff K. Revisiting reliable change with Iverson (2001). Clin Neuropsychol 38:412-428, 2024. DOI: 10.1080/13854046.2023.2202333\n\nDuff K, Dixon A, Embree L. A Closer Look at Practice Effects in Mild Cognitive Impairment and Alzheimer's Disease. Arch Clin Neuropsychol 39:1-10, 2024. PMC10802223. DOI: 10.1093/arclin/acad046\n\nElliott JE, Bryant-Ekstrand MD, Keil AT, Ligman BR, Lim MM, Zitser J, During EH, Gagnon JF, St Louis EK, Fields JA, Huddleston DE, Bliwise DL, Avidan AY, Schenck CH, McLeland J, Criswell SR, Davis AA, Videnovic A, Lee-Iannotti JK, Postuma R, Boeve BF, Ju YS, Miglis MG; for North American Prodromal Synucleinopathy (NAPS) Consortium. Frequency of Orthostatic Hypotension in Isolated REM Sleep Behavior Disorder. Neurology. 2023 Dec 12;101(24):e2545-e2559. doi: 10.1212/WNL.0000000000207883. Epub 2023 Oct 19. PMID: 37857496; PMCID: PMC10791057.\n\nElliott JE, Ligman BR, Bryant-Ekstrand MD, Keil AT, Powers K, Olivo C, Neilson L, Postuma RB, Pelletier A, Gagnon JF, Gan-Or Z, Yu E, Liu L, St Louis EK, Forsberg LK, Fields JA, Ross OA, Huddleston DE, Bliwise DL, Avidan AY, Howell MJ, Schenck CH, McLeland J, Criswell SR, Videnovic A, During EH, Miglis MG, Shprecher DR, Lee-Iannotti JK, Boeve BF, Ju YS, Lim MM. Comorbid neurotrauma increases neurodegenerative-relevant cognitive, motor, and autonomic dysfunction in patients with REM sleep behavior disorder: A substudy of the North American Prodromal Synucleinopathy Consortium. Sleep, 2024. DOI: 10.1093/sleep/zsae007\n\nGauthreaux K, Kukull WA, Nelson KB, Mock C, Chen YC, Chan KCG, Fardo DW, Katsumata Y, Abner EL, Nelson PT. Different cohort, disparate results: Selection bias is a key factor in autopsy cohorts. Alzheimers Dement. 2024 Jan;20(1):266-277. doi: 10.1002/alz.13422. Epub 2023 Aug 17. PMID: 37592813; PMCID: PMC10843760.\n\nGinder DE, Tinsley CE, Kaiser ME, Lim MM. Sex-Specific Impacts of Early Life Sleep Disruption: Ethanol Seeking, Social Interaction, and Anxiety Are Differentially Altered in Adolescent Prairie Voles. bioRxiv, 2024. PMC10802381. DOI: 10.1101/2024.01.03.574112\n\nGray NE, Hack W, Brandes MS, Zweig JA, Yang L, Marney L, Choi J, Magana AA, Cerruti N, McFerrin J, Koike S, Nguyen T, Raber J, Quinn JF, Maier CS, Soumyanath A. Amelioration of age-related cognitive decline and anxiety in mice by Centella asiatica extract varies by sex, dose and mode of administration. bioRxiv [Preprint]. 2024 Jan 24:2024.01.23.576700. doi: 10.1101/2024.01.23.576700. PMID: 38328129; PMCID: PMC10849617.\n\nHiya S, Maldonado-Díaz C, Walker JM, Richardson TE. Cognitive symptoms progress with limbic-predominant age-related TDP-43 encephalopathy stage and co-occurrence with Alzheimer disease. J Neuropathol Exp Neurol. 2023 Dec 22;83(1):2-10. doi: 10.1093/jnen/nlad098. PMID: 37966908; PMCID: PMC10746699.\n\nLi D, Farrell JJ, Mez J, Martin ER, Bush WS, Ruiz A, Boada M, de Rojas I, Mayeux R, Haines JL, Vance MAP, Wang LS, Schellenberg GD, Lunetta KL, Farrer LA. Novel loci for Alzheimer's disease identified by a genome-wide association study in Ashkenazi Jews. Alzheimers Dement. 2023 Dec;19(12):5550-5562. doi: 10.1002/alz.13117. Epub 2023 Jun 1. PMID: 37260021; PMCID: PMC10689571.\n\nLiampas I, Siokas V, Lyketsos CG, Dardiotis E. Cognitive Performance and Incident Alzheimer's Dementia in Men Versus Women. J Prev Alzheimers Dis 11:162-170, 2024. PMC10794850. DOI: 10.14283/jpad.2023.90\n\nPleasant T, Ono S, Gothard S, Wall R, Silbert L. Aging Veterans and a Silver Lining of Service. J Veterans Stud. 2023;9(3):98-102. doi: 10.21061/jvs.v9i3.495. Epub 2023 Dec 20. PMID: 38390452; PMCID: PMC10883328.\n\nSandau US, Magana SM, Costa J, Nolan JP, Ikezu T, Vella LJ, Jackson HK, Moreira LR, Palacio PL, Hill AF, Quinn JF, Van Keuren-Jensen KR, McFarland TJ, Palade J, Sribnick EA, Su H, Vekrellis K, Coyle B, Yang Y, Falcon-Perez JM, Nieuwland R, Saugstad JA. Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies. J Extracell Vesicles 13:e12397, 2024. PMC10756860. DOI: 10.1002/jev2.12397\n\nSandau US, Wiedrick JT, McFarland TJ, Galasko DR, Fanning Z, Quinn JF, Saugstad JA. Analysis of the longitudinal stability of human plasma miRNAs and implications for disease biomarkers. Sci Rep 14:2148, 2024. PMC10810819. DOI: 10.1038/s41598-024-52681-5\n\nShaw JS, Leoutsakos JM, Rosenberg PB. The Relationship Between First Presenting Neuropsychiatric Symptoms in Older Adults and Autopsy-Confirmed Memory Disorders. Am J Geriatr Psychiatry. 2024 Jan 17:S1064-7481(24)00015-0. doi: 10.1016/j.jagp.2024.01.015. Epub ahead of print. PMID: 38296755.\n\nThomas JH, Nilaver B, Lomniczi A, Brown D, Appleman M, Kohama S, Urbanski H. Pathological markers of Alzheimer’s disease and related dementia in the rhesus macaque amygdala. Journal of Alzheimer’s Disease Reports 8:25-32, 2024. PMC10790150. DOI: 10.3233/ADR-230184\n\nWebber TA, Lorkiewicz SA, Kiselica AM, Woods SP. Ecological validity of cognitive fluctuations in dementia with Lewy bodies. J Int Neuropsychol Soc. 2024 Jan;30(1):35-46. doi: 10.1017/S1355617723000255. Epub 2023 Apr 14. PMID: 37057867; PMCID: PMC10576013.\n\nYamamoto E, Koike S, Luther M, Dennis L, Lim MM, Raskind M, Pagulayan K, Iliff J, Peskind E, Piantino J. Perivascular space burden and cerebrospinal fluid biomarkers in U.S. Veterans with blast-related mild traumatic brain injury. J Neurotrauma, 2024. DOI: 10.1089/neu.2023.0505\n\nZhang Q, Fan C, Wang L, Li T, Wang M, Han Y, Jiang J; and for the Alzheimer’s Disease Neuroimaging Initiative. Glucose metabolism in posterior cingulate cortex has supplementary value to predict the progression of cognitively unimpaired to dementia due to Alzheimer's disease: an exploratory study of 18F-FDG-PET. Geroscience. 2024 Feb;46(1):1407-1420. doi: 10.1007/s11357-023-00897-0. Epub 2023 Aug 23. PMID: 37610594; PMCID: PMC10828178.\n\nAl Olaimat M, Martinez J, Saeed F, Bozdag S. PPAD: a deep learning architecture to predict progression of Alzheimer's disease. Bioinformatics 39:i149-i157, 2023. PMC10311312. DOI: 10.1101/2023.01.28.526045\n\nAndruchow D, Cunningham D, Sharma MJ, Ismail Z, Callahan BL. Characterizing mild cognitive impairment to predict incident dementia in adults with bipolar disorder: What should the benchmark be? Clin Neuropsychol. 2023 Oct;37(7):1455-1478. doi: 10.1080/13854046.2022.2135605. Epub 2022 Oct 29. PMID: 36308307. DOI: 10.1080/13854046.2022.2135605\n\nArcher DB, Eissman JM, Mukherjee S, Lee ML, Choi SE, Scollard P, Trittschuh EH, Mez JB, Bush WS, Kunkle BW, Naj AC, Gifford KA; Alzheimer's Disease Neuroimaging Initiative (ADNI); Alzheimer's Disease Genetics Consortium (ADGC); Alzheimer's Disease Sequencing Project (ADSP); Cuccaro ML, Pericak-Vance MA, Farrer LA, Wang LS, Schellenberg GD, Mayeux RP, Haines JL, Jefferson AL, Kukull WA, Keene CD, Saykin AJ, Thompson PM, Martin ER, Bennett DA, Barnes LL, Schneider JA, Crane PK, Dumitrescu L, Hohman TJ. Longitudinal change in memory performance as a strong endophenotype for Alzheimer's disease. Alzheimers Dement. 2023 Nov 20. doi: 10.1002/alz.13508. Epub ahead of print. PMID: 37985223. DOI: 10.1002/alz.13508\n\nAzevedo T, Bethlehem RAI, Whiteside DJ, Swaddiwudhipong N, Rowe JB, Lio P, Rittman T, Alzheimer's Disease Neuroimaging Initiative. Identifying healthy individuals with Alzheimer's disease neuroimaging phenotypes in the UK Biobank. Commun Med (Lond) 3:100, 2023. PMC10359360. DOI: 10.1038/s43856-023-00313-w\n\nBabulal GM, Zhu Y, Trani JF. Racial and ethnic differences in neuropsychiatric symptoms and progression to incident cognitive impairment among community-dwelling participants. Alzheimers Dement 19:3635-3643, 2023. DOI: 10.1002/alz.12988\n\nBai H, Naj AC, Benchek P, Dumitrescu L, Hohman T, Hamilton-Nelson K, Kallianpur AR, Griswold AJ, Vardarajan B, Martin ER, Beecham GW, Below JE, Schellenberg G, Mayeux R, Farrer L, Pericak-Vance MA, Haines JL, Bush WS; Alzheimer's Disease Genetics Consortium. A haptoglobin (HP) structural variant alters the effect of APOE alleles on Alzheimer's disease. Alzheimers Dement. 2023 Nov;19(11):4886-4895. doi: 10.1002/alz.13050. Epub 2023 Apr 12. PMID: 37051669. DOI: 10.1002/alz.13050\n\nBerridge C, Turner NR, Liu L, Fredriksen-Goldsen KI, Lyons KS, Demiris G, Kaye J, Lober WB. Preliminary Efficacy of Let's Talk Tech: Technology Use Planning for Dementia Care Dyads. Innov Aging 7:igad018, 2023. PMC10132307. DOI: 10.1093/geroni/igad018\n\nBerridge C, Zhou Y, Robillard J, Kaye J. Companion robots to mitigate loneliness among older adults: Perceptions of benefit and possible deception. Frontiers: Psychology of Aging 21:1106633, 2023. PMC9988932. DOI: 10.3389/fpsyg.2023.1106633\n\nBerridge C, Zhou Y, Robillard J, Kaye J. AI Companion Robot Data Sharing: Preferences of an Online Cohort and Policy Implications. Journal of Elder Policy 2:19-54, 2023.\n\nBocancea DI, Svenningsson AL, van Loenhoud AC, Groot C, Barkhof F, Strandberg O, Smith R, La Joie R, Rosen HJ, Pontecorvo MJ, Rabinovici GD, van der Flier WM, Hansson O, Ossenkoppele R, Alzheimer’s Disease Neuroimaging Initiative. Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis. Brain 146:3719-3734, 2023. PMC10473572. DOI: 10.1093/brain/awad100\n\nBollinger RM, Gabel M, Coble DW, Chen SW, Keleman AA, Doralus J, Chin E, Lingler JH, Grill JD, Stark SL, Edwards DF. Retention of Study Partners in Longitudinal Studies of Alzheimer Disease. Journal of Alzheimer's Disease 94:189-199, 2023. DOI: 10.3233/JAD-230079\n\nBouzid H, Belk JA, Jan M, Qi Y, Sarnowski C, Wirth S, Ma L, Chrostek MR, Ahmad H, Nachun D, Yao W, Consortium NT-OfPM, Beiser A, Bick AG, Bis JC, Fornage M, Longstreth WT, Jr., Lopez OL, Natarajan P, Psaty BM, Satizabal CL, Weinstock J, Larson EB, Crane PK, Keene CD, Seshadri S, Satpathy AT, Montine TJ, Jaiswal S. Clonal hematopoiesis is associated with protection from Alzheimer's disease. Nat Med 29:1662-1670, 2023. PMC10353941. DOI: 10.1038/s41591-023-02397-2\n\nBueno-Junior LS, Jones-Tinsley CE, Milman NEP, Wickham PT, Watson BO, Lim MM. Early-life sleep disruption impairs subtle social behaviours in prairie voles: a pose-estimation study. R Soc Open Sci 10:230700, 2023. PMC10336370. DOI: 10.1098/rsos.230700\n\nCannizzaro A, Ronat L, El Haffaf LM, Hanganu A. Associations between neuropsychiatric symptoms of affective and vegetative domains and brain morphology in aging people with mild cognitive impairment and Alzheimer's disease. Int J Geriatr Psychiatry 38:e5952, 2023. DOI: 10.1002/gps.5952\n\nChemparathy A, Guen YL, Chen S, Lee EG, Leong L, Gorzynski J, Xu G, Belloy M, Kasireddy N, Tauber AP, Williams K, Stewart I, Wingo T, Lah J, Jayadev S, Hales C, Peskind E, Child DD, Keene CD, Cong L, Ashley E, Yu CE, Greicius MD. APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer's Disease pathology. medRxiv, 2023. 10402217. DOI: 10.1101/2023.07.20.23292771\n\nChen XR, Shao Y, Sadowski MJ, Alzheimer's Disease Neuroimaging Initiative. Interaction between KLOTHO-VS Heterozygosity and APOE epsilon4 Allele Predicts Rate of Cognitive Decline in Late-Onset Alzheimer's Disease. Genes (Basel) 14, 2023. PMC10137709. DOI: 10.3390/genes14040917\n\nCorrero Ii AN, Gauthreaux K, Perales-Puchalt J, Chen YC, Chan KCG, Kukull WA, Flatt JD. Cognitive Aging with Dementia, Mild Cognitive Impairment, or No Impairment: A Comparison of Same- and Mixed-Sex Couples. Journal of Alzheimer's Disease 92:109-128, 2023. PMC10029351. DOI: 10.3233/JAD-220309\n\nDato S, De Rango F, Crocco P, Pallotti S, Belloy ME, Le Guen Y, Greicius MD, Passarino G, Rose G, Napolioni V. Sex- and APOE-specific genetic risk factors for late-onset Alzheimer's disease: Evidence from gene-gene interaction of longevity-related loci. Aging Cell 22:e13938, 2023. PMC10497850. DOI: 10.1111/acel.13938\n\nDawson W, Booi L, Pintado-Caipa M, Okada de Oliveira M, Kornhuber A, Spoden N, Golonka O, Davidziuk A, Vergara Manríquez M, Cominetti M, Kochhann R, Robertson I, Eyre H, Ibáñez A. The Brain Health Diplomat’s Toolkit. Supporting Brain Health Diplomacy Leaders in Latin America and the Caribbean. Latin American Brain Health Institute (BrainLat). 2023.\n\nDe Francesco S, Crema C, Archetti D, Muscio C, Reid RI, Nigri A, Bruzzone MG, Tagliavini F, Lodi R, D'Angelo E, Boeve B, Kantarci K, Firbank M, Taylor JP, Tiraboschi P, Redolfi A; RIN – Neuroimaging Network. Differential diagnosis of neurodegenerative dementias with the explainable MRI based machine learning algorithm MUQUBIA. Sci Rep. 2023 Oct 13;13(1):17355. doi: 10.1038/s41598-023-43706-6. Erratum in: Sci Rep. 2024 Jan 18;14(1):1603. PMID: 37833302; PMCID: PMC10575864. DOI: 10.1038/s41598-023-43706-6\n\nDeVettori G, Troxel WM, Duff K, Baron KG. Positive airway pressure adherence among patients with obstructive sleep apnea and cognitive impairment: A narrative review. Sleep Med 111:28-35, 2023. DOI: 10.1016/j.sleep.2023.08.029\n\nDiaz-Castro B, Robel S, Mishra A. Astrocyte Endfeet in Brain Function and Pathology: Open Questions. Annu Rev Neurosci 46:101-121, 2023. DOI: 10.1146/annurev-neuro-091922-031205\n\nDuff K, Dixon AM, Embree L, Hoffman JM. Change on the Repeatable Battery for the Assessment of Neuropsychological Status and its relationship to brain amyloid. Journal of Clinical and Experimental Neuropsychology 45:105-117, 2023. DOI: 10.1080/13803395.2023.2216920\n\nDuff K, Wan L, Embree L, Hoffman JM. Change in the Quick Dementia Rating System Across Time in Older Adults with and without Cognitive Impairment. Journal of Alzheimer's Disease 93:449-457, 2023. DOI: 10.3233/JAD-221252\n\nEissman JM, Archer DB, Mukherjee S, Lee ML, Choi SE, Scollard P, Trittschuh EH, Mez JB, Bush WS, Kunkle BW, Naj AC, Gifford KA; Alzheimer's Disease Neuroimaging Initiative (ADNI) | Alzheimer's Disease Genetics Consortium (ADGC) | The Alzheimer's Disease Sequencing Project (ADSP); Cuccaro ML, Cruchaga C, Pericak-Vance MA, Farrer LA, Wang LS, Schellenberg GD, Mayeux RP, Haines JL, Jefferson AL, Kukull WA, Keene CD, Saykin AJ, Thompson PM, Martin ER, Bennett DA, Barnes LL, Schneider JA, Crane PK, Hohman TJ, Dumitrescu L. Sex-specific genetic architecture of late-life memory performance. Alzheimers Dement. 2023 Nov 20. doi: 10.1002/alz.13507. Epub ahead of print. PMID: 37984853. DOI: 10.1002/alz.13507\n\nElliott JE, Ligman BR, Bryant-Ekstrand MD, Keil AT, Powers K, Olivo C, Neilson L, Postuma RB, Pelletier A, Gagnon JF, Gan-Or Z, Yu E, Liu L, St Louis EK, Forsberg LK, Fields JA, Ross OA, Huddleston DE, Bliwise DL, Avidan AY, Howell MJ, Schenck CH, McLeland J, Criswell SR, Videnovic A, During EH, Miglis MG, Shprecher DR, Lee-Iannotti JK, Boeve BF, Ju YS, Lim MM; North American Prodromal Synucleinopathy (NAPS) Consortium. Comorbid neurotrauma increases neurodegenerative-relevant cognitive, motor, and autonomic dysfunction in patients with REM sleep behavior disorder: A substudy of the North American Prodromal Synucleinopathy Consortium. Sleep. 2024 Jan 5:zsae007. doi: 10.1093/sleep/zsae007. Epub ahead of print. PMID: 38181205. DOI: 10.1093/sleep/zsae007\n\nEuler MJ, Duff K, King JB, Hoffman JM. Recall and recognition subtests of the repeatable battery for the assessment of neuropsychological status and their relationship to biomarkers of Alzheimer's disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2023 Sep-Nov;30(6):885-902. doi: 10.1080/13825585.2022.2124229. Epub 2022 Sep 15. PMID: 36110031; PMCID: PMC10014490. DOI: 10.1080/13825585.2022.2124229\n\nEyre H, Dawson W, Abbott R, Silverman K, Chen S, Ayadi R, Carnevale S, Wong S, Berk M, Nanda U, Ling G, Tempest M, Occhipinti J, Shah S, Mahfouz J, Fu E, MacRae I, Esquive G, Edmonds T, Jacka F, Hynes W, Wickerson G, Swieboda P. Toward a Comprehensive Brain Deal to Harness the Potential of Artificial Intelligence., 2023.\n\nEyre H, Stirland L, Jeste D, Reynolds C, Berk M, Ibanez A, Dawson W, Lawlor B, Leroi I, Yaffe K, Gatchel J, Karp J, Newhouse P, Rosand J, Letourneau N, Bayen E, Farina F, Booi L, Devanand D, Mintzer J, Madigan S, Jayapurwala I, Wong S, Falcoa V, Cummings J, Reichman W, Lock S, Bennett M, Ahuja R, Steffens D, Elkind M, Lavretsky H. Life-Course Brain Health as a Determinant of Late-Life Mental Health: American Association for Geriatric Psychiatry Expert Panel Recommendations. American Journal of Geriatric Psychiatry:1-27, 2023.\n\nFowe IE, Wallace NT, Kaye J. The Association of Learning Health System Practicing Hospitals and other Health Information Interested Hospitals with Patient-Generated Health Data Uptake. AMIA Jt Summits Transl Sci Proc 2023:176-185, 2023. PMC10283141.\n\nFracassi A, Marcatti M, Tumurbaatar B, Woltjer R, Moreno S, Taglialatela G. TREM2-induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer's neuropathology. Brain Pathology 33:e13108, 2023. DOI: 10.1111/bpa.13108\n\nGuevara JE, Kurniadi NE, Duff K. Assessing Longitudinal Cognitive Change in Mild Cognitive Impairment Using Estimated Standardized Regression-Based Formulas. Journal of Alzheimer's Disease, 2023. DOI: 10.3233/JAD-230160\n\nHantke N, Kaye J, Mattek N, Wu C, Dodge H, Beattie Z, Woltjer R. Correlating continuously captured home-based digital biomarkers of daily function with postmortem neurodegenerative neuropathology. PLoS One 18:e0286812, 2023. PMC10249904. DOI: 10.1371/journal.pone.0286812\n\nHartz SM, Mozersky J, Schindler SE, Linnenbringer E, Wang J, Gordon BA, Raji CA, Moulder KL, West T, Benzinger TLS, Cruchaga C, Hassenstab JJ, Bierut LJ, Xiong C, Morris JC. A flexible modeling approach for biomarker-based computation of absolute risk of Alzheimer's disease dementia. Alzheimers Dement 19:1452-1465, 2023. PMC10060442. DOI: 10.1002/alz.12781\n\nHicks A, Sinclair B, Shultz S, Pham W, Silbert LC, Schwartz DL, Rowe CC, Ponsford JL, Law M, Spitz G. Associations of Enlarged Perivascular Spaces With Brain Lesions, Brain Age, and Clinical Outcomes in Chronic Traumatic Brain Injury. Neurology, 2023. DOI: 10.1212/WNL.0000000000207370\n\nHicks B, Kaye JA, Azoulay L, Kristensen KB, Habel LA, Pottegard A. The application of lag times in cancer pharmacoepidemiology: a narrative review. Ann Epidemiol 84:25-32, 2023. DOI: 10.1016/j.annepidem.2023.05.004\n\nHiya S, Maldonado-Diaz C, Walker JM, Richardson TE. Cognitive symptoms progress with limbic-predominant age-related TDP-43 encephalopathy stage and co-occurrence with Alzheimer disease. Journal of Neuropathology and Experimental Neurology 83:2-10, 2023. PMC10746699. DOI: 10.1093/jnen/nlad098\n\nHlauschek G, Lossius MI, Schwartz DL, Silbert LC, Hicks AJ, Ponsford JL, Vivash L, Sinclair B, Kwan P, O'Brien TJ, Shultz SR, Law M, Spitz G. Reduced total number of enlarged perivascular spaces in post-traumatic epilepsy patients with unilateral lesions - a feasibility study. Seizure. 2023 Dec;113:1-5. doi: 10.1016/j.seizure.2023.10.006. Epub 2023 Oct 13. PMID: 37847935. DOI: 10.1016/j.seizure.2023.10.006\n\nHolden SK, Bedenfield N, Taylor AS, Bayram E, Schwilk C, Fleisher J, Duda J, Shill H, Paulson HL, Stacy K, Wood J, Corsentino P, Sha SJ, Litvan I, Irwin DJ, Quinn JF, Goldman JG, Amodeo K, Taylor JP, Boeve BF, Armstrong MJ. Research Priorities of Individuals and Caregivers With Lewy Body Dementia: A Web-based Survey. Alzheimer Disease and Associated Disorders 37:50-58, 2023. PMC9971616. DOI: 10.1097/WAD.0000000000000545\n\nHuie EZ, Escudero A, Saito N, Harvey D, Nguyen ML, Lucot KL, LaGrande J, Mungas D, DeCarli C, Lamar M, Schneider JA, Kapasi A, Rissman RA, Teich AF, Dugger BN. TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups. Journal of Alzheimer's Disease 91:1291-1301, 2023. DOI: 10.3233/JAD-220558\n\nJo T, Kim J, Bice P, Huynh K, Wang T, Arnold M, Meikle PJ, Giles C, Kaddurah-Daouk R, Saykin AJ, Nho K, Alzheimer's Disease Metabolomics Consortium, Alzheimer's Disease Neuroimaging Initiative. Circular-SWAT for deep learning based diagnostic classification of Alzheimer's disease: application to metabolome data. EBioMedicine 97:104820, 2023. PMC10579282. DOI: 10.1016/j.ebiom.2023.104820\n\nKallianpur KJ, Masaki KH, Chen R, Willcox BJ, Allsopp RC, Davy P, Dodge HH. Weak Social Networks in Late Life Predict Incident Alzheimer's Disease: The Kuakini Honolulu-Asia Aging Study. J Gerontol A Biol Sci Med Sci 78:663-672, 2023. PMC10061568. DOI: 10.1093/gerona/glac215\n\nKaser AN, Kaplan DM, Goette W, Kiselica AM. The impact of conventional versus robust norming on cognitive characterization and clinical classification of MCI and dementia. J Neuropsychol 17:108-124, 2023. PMC10006397. DOI: 10.1111/jnp.12289\n\nKatsumata Y, Fardo DW, Shade LMP, Alzheimer's Disease Genetics Consortium, Nelson PT. LATE-NC risk alleles (in TMEM106B, GRN, and ABCC9 genes) among persons with African ancestry. Journal of Neuropathology and Experimental Neurology 82:760-768, 2023. PMC10440720. DOI: 10.1093/jnen/nlad059\n\nKeil SA, Schindler AG, Wang MX, Piantino J, Silbert LC, Elliott JE, Lim MM, Thomas RG, Willis S, Iliff JJ. Instability in longitudinal sleep duration predicts cognitive impairment in aged participants of the Seattle Longitudinal Study. medRxiv, 2023. PMC10312848. DOI: 10.1101/2023.06.07.23291098\n\nKeil SA, Schindler AG, Wang MX, Piantino J, Silbert LC, Elliott JE, Werhane ML, Thomas RG, Willis S, Lim MM, Iliff JJ. Longitudinal Sleep Patterns and Cognitive Impairment in Older Adults. JAMA Netw Open 6:e2346006, 2023. PMC10696486. DOI: 10.1001/jamanetworkopen.2023.46006\n\nKim H, Senders A, Simeon E, Juarez C, Huang S, Dodge H, McConnell KJ. Use of long-term services and supports among dual-eligible beneficiaries with Alzheimer's disease and related dementias. Journal of the American Geriatrics Society 71:432-442, 2023. PMC9957784. DOI: 10.1111/jgs.18115\n\nKlein E, Montes Daza N, Dasgupta I, MacDuffie K, Schonau A, Flynn G, Song D, Goering S. Views of stakeholders at risk for dementia about deep brain stimulation for cognition. Brain Stimul 16:742-747, 2023.DOI: 10.1016/j.brs.2023.04.007\n\nKoppelmans V, Ruitenberg MFL, Schaefer SY, King JB, Hoffman JM, Mejia AF, Tasdizen T, Duff K. Delayed and More Variable Unimanual and Bimanual Finger Tapping in Alzheimer's Disease: Associations with Biomarkers and Applications for Classification. Journal of Alzheimer's Disease, 2023. PMC in Process. DOI: 10.3233/JAD-221297\n\nLee G, Nho K, Kang B, Sohn KA, Kim D, Alzheimer's Disease Neuroimaging Initiative. Author Correction: Predicting Alzheimer's disease progression using multi-modal deep learning approach. Sci Rep 13:12466, 2023. PMC10393953. DOI: 10.1038/s41598-023-39138-x\n\nLeese MI, Mattek N, Bernstein JPK, Dorociak KE, Gothard S, Kaye J, Hughes AM. The Survey for Memory, Attention, and Reaction Time (SMART): Preliminary normative online panel data and user attitudes for a brief web-based cognitive performance measure. Clin Neuropsychol 37:1257-1275, 2023. PMC9899293. DOI: 10.1080/13854046.2022.2103033\n\nLennon J, Hantke N, Mattek N, C W, Dodge H, Wall R, Beattie Z, Kaye J, Silbert L. Mood and activity changes during the Covid-19 pandemic in rural and urban Veterans and their cohabitants. Clinical Gerontologist 8:1-8, Forthcoming, 2023. PMC10132474. DOI: 10.1080/07317115.2022.2130123\n\nLeung Y, Barzilai N, Batko-Szwaczka A, Beker N, Boerner K, Brayne C, Brodaty H, Cheung KS, Corrada MM, Crawford JD, Galbussera AA, Gondo Y, Holstege H, Hulsman M, Ishioka YL, Jopp D, Kawas CH, Kaye J, Kochan NA, Lau BH, Lipnicki DM, Lo JW, Lucca U, Makkar SR, Marcon G, Martin P, Meguro K, Milman S, Poon LW, Recchia A, Ribeiro O, Riva E, Rott C, Sikkes SA, Skoog I, Stephan B, Szewieczek J, Teixeira L, Tettamanti M, Wilczynski K, Sachdev P. Cognition, function, and prevalent dementia in centenarians and near-centenarians: An individual participant data (IPD) meta-analysis of 18 studies. Alzheimers Dement 19:2265-2275, 2023. DOI: 10.1002/alz.12828\n\nLi D, Farrell JJ, Mez J, Martin ER, Bush WS, Ruiz A, Boada M, de Rojas I, Mayeux R, Haines JL, Vance MAP, Wang LS, Schellenberg GD, Lunetta KL, Farrer LA. Novel loci for Alzheimer's disease identified by a genome-wide association study in Ashkenazi Jews. Alzheimers Dement 19:5550-5562, 2023. PMC10689571. DOI: 10.1002/alz.13117\n\nLi H, Liu H, Lutz MW, Luo S, Alzheimer's Disease Neuroimaging I. Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive Impairment to Alzheimer's Disease. Journal of Alzheimer's Disease 91:977-987, 2023. PMC9905310. DOI: 10.3233/JAD-220680\n\nLiampas I, Siokas V, Lyketsos CG, Dardiotis E. Associations between neuropsychiatric symptoms and incident Alzheimer's dementia in men versus women. Journal of Neurology 270:2069-2083, 2023. PMC10025238. DOI: 10.1007/s00415-022-11541-w\n\nLindauer A, Smith S, Gothard S, Mattek N, Tran L, Mooney A. There’s no straight line… a consumer-informed intervention for FTD family care partners: the STELLA-FTD pilot study. Aging and Mental Health:1-11, 2023. DOI: 10.1080/13607863.2023.2250741\n\nMalek-Ahmadi M, Duff K, Chen K, Su Y, King JB, Koppelmans V, Schaefer SY. Volumetric regional MRI and neuropsychological predictors of motor task variability in cognitively unimpaired, Mild Cognitive Impairment, and probable Alzheimer's disease older adults. Exp Gerontol 173:112087, 2023. PMC9974847. DOI: 10.1016/j.exger.2023.112087\n\nMarquine MJ, Parks A, Perales-Puchalt J, Gonzalez DA, Rosado-Bruno M, North R, Pieper C, Werry AE, Kiselica A, Chapman S, Dodge H, Gauthreaux K, Kukull WA, Rascovsky K. Demographically-adjusted normative data among Latinos for the version 3 of the Alzheimer's Disease Centers' Neuropsychological Test Battery in the Uniform Data Set. Alzheimers Dement 19: 4174-4186, 2023. DOI: 10.1002/alz.13313\n\nMcDonough IM, Cody SL, Harrell ER, Garrett SL, Popp TE. Cognitive differences across ethnoracial category, socioeconomic status across the Alzheimer's disease spectrum: Can an ability discrepancy score level the playing field? Mem Cognit 51:543-560, 2023. DOI: 10.3758/s13421-022-01304-3\n\nMcLachlan E, Ocal D, Burgess N, Reeves S, Howard R, Alzheimer’s Disease Neuroimaging Initiative. Association Between False Memories and Delusions in Alzheimer Disease. JAMA Psychiatry 80:700-709, 2023. PMC10209823. DOI: 10.1001/jamapsychiatry.2023.1012\n\nMerrill NJ, Davidson WS, He Y, Diaz Ludovico I, Sarkar S, Berger MR, McDermott JE, Van Eldik LJ, Wilcock DM, Monroe ME, Kyle JE, Bruce KD, Heinecke JW, Vaisar T, Raber J, Quinn JF, Melchior JT. Human cerebrospinal fluid contains diverse lipoprotein subspecies enriched in proteins implicated in central nervous system health. Sci Adv 9:eadi5571, 2023. PMC10468133. DOI: 10.1126/sciadv.adi5571\n\nMonin JK, McAvay G, Zang E, Vander Wyk B, Carrion CI, Allore H. Associations between dementia staging, neuropsychiatric behavioral symptoms, and divorce or separation in late life: A case control study. PLoS One 18:e0289311, 2023. PMC10431668. DOI: 10.1371/journal.pone.0289311\n\nMuurling M, Au-Yeung WM, Beattie Z, Wu CY, Dodge H, Rodrigues NK, Gothard S, Silbert LC, Barnes LL, Steele JS, Kaye J. Differences in Life Space Activity Patterns Between Older Adults With Mild Cognitive Impairment Living Alone or as a Couple: Cohort Study Using Passive Activity Sensing. JMIR Aging 6:e45876, 2023. PMC10600648. DOI: 10.2196/45876\n\nNagaraja N, Wang WE, Duara R, DeKosky ST, Vaillancourt D. Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease. Journal of Alzheimer's Disease 93:495-507, 2023. DOI: 10.3233/JAD-220624\n\nNguyen HD, Clément M, Planche V, Mansencal B, Coupé P. Deep grading for MRI-based differential diagnosis of Alzheimer's disease and Frontotemporal dementia. Artif Intell Med. 2023 Oct;144:102636. doi: 10.1016/j.artmed.2023.102636. Epub 2023 Aug 18. PMID: 37783553. DOI: 10.1016/j.artmed.2023.102636\n\nNilaver B, Urbanski H. Mechanisms underlying TDP-43 pathology and neurodegeneration: an updated mini-review. Frontiers in Aging Neuroscience 15:1142617, 2023. PMC in Process. DOI: 10.3389/fnagi.2023.1142617\n\nOhrfelt A, Benedet AL, Ashton NJ, Kvartsberg H, Vandijck M, Weiner MW, Trojanowski JQ, Shaw LM, Zetterberg H, Blennow K, Alzheimer's Disease Neuroimaging. Association of CSF GAP-43 With the Rate of Cognitive Decline and Progression to Dementia in Amyloid-Positive Individuals. Neurology 100:e275-e285, 2023. PMC9869758. DOI: 10.1212/WNL.0000000000201417\n\nPang Y, Kukull W, Sano M, Albin RL, Shen C, Zhou J, Dodge HH. Predicting Progression from Normal to MCI and from MCI to AD Using Clinical Variables in the National Alzheimer's Coordinating Center Uniform Data Set Version 3: Application of Machine Learning Models and a Probability Calculator. J Prev Alzheimers Dis 10:301-313, 2023. PMC10033942. DOI: 10.14283/jpad.2023.10\n\nPhongpreecha T, Godrich D, Berson E, Espinosa C, Kim Y, Cholerton B, Chang AL, Mataraso S, Bukhari SA, Perna A, Yakabi K, Montine KS, Poston KL, Mormino E, White L, Beecham G, Aghaeepour N, Montine TJ. Quantitative estimate of cognitive resilience and its medical and genetic associations. Alzheimers Res Ther. 2023 Nov 6;15(1):192. doi: 10.1186/s13195-023-01329-z. PMID: 37926851; PMCID: PMC10626669. DOI: 10.1186/s13195-023-01329-z\n\nPiau A, Steinmeyer Z, Mattek N, Lindaeuer A, Sharma N, Bouranis N, Wild K, Kaye J. Caregiving in Older Adults; Experiences and Attitudes toward Smart Technologies. Journal of Clinical Medicine 12:1789, 2023. PMC10003197. DOI: 10.3390/jcm12051789\n\nPillai JA, Bena J, Maly EF, Leverenz JB. Initial non-amnestic symptoms relate to faster rate of functional and cognitive decline compared to amnestic symptoms in neuropathologically confirmed dementias. Alzheimers Dement 19:2956-2965, 2023. PMC10350479. DOI: 10.1002/alz.12922\n\nPirraglia E, Glodzik L, Shao Y. Lower mortality risk in APOE4 carriers with normal cognitive ageing. Sci Rep 13:15089, 2023. PMC10497512. DOI: 10.1038/s41598-023-41078-5\n\nPleasant T, Ono S, Gothard S, Wall R, Silbert L. Aging Veterans and a Silver Lining of Service. Journal of Veterans Studies:98-102, 2023.\n\nPolsinelli AJ, Lane KA, Manchella MK, Logan PE, Gao S, Apostolova LG. APOE epsilon4 is associated with earlier symptom onset in LOAD but later symptom onset in EOAD. Alzheimers Dement 19:2212-2217, 2023. PMC10182241. DOI: 10.1002/alz.12955\n\nPolsinelli AJ, Logan PE, Lane KA, Manchella MK, Nemes S, Sanjay AB, Gao S, Apostolova LG. APOE epsilon4 carrier status and sex differentiate rates of cognitive decline in early- and late-onset Alzheimer's disease. Alzheimers Dement 19:1983-1993, 2023. PMC10182251. DOI: 10.1002/alz.12831\n\nProkai L, Nguyen V, Urbanski HF. Effect of estradiol replacement on hippocampal concentrations of estrogens in aged rhesus macaques maintained on an obesogenic diet. Biochem Biophys Rep 35:101548, 2023. PMC10511332. DOI: 10.1016/j.bbrep.2023.101548\n\nQin Y, Han H, Li Y, Cui J, Jia H, Ge X, Ma Y, Bai W, Zhang R, Chen D, Yi F, Yu H. Estimating Bidirectional Transitions and Identifying Predictors of Mild Cognitive Impairment. Neurology 100:e297-e307, 2023. PMC9869761. DOI: 10.1212/WNL.0000000000201386\n\nRaber J, Silbert LC. Role of white matter hyperintensity in effects of apolipoprotein E on cognitive injury. Front Hum Neurosci 17:1176690, 2023. PMC10237322. DOI: 10.3389/fnhum.2023.1176690\n\nRajabli F, Benchek P, Tosto G, Kushch N, Sha J, Bazemore K, Zhu C, Lee WP, Haut J, Hamilton-Nelson KL, Wheeler NR, Zhao Y, Farrell JJ, Grunin MA, Leung YY, Kuksa PP, Li D, Lucio da Fonseca E, Mez JB, Palmer EL, Pillai J, Sherva RM, Song YE, Zhang X, Iqbal T, Pathak O, Valladares O, Kuzma AB, Abner E, Adams PM, Aguirre A, Albert MS, Albin RL, Allen M, Alvarez L, Apostolova LG, Arnold SE, Asthana S, Atwood CS, Ayres G, Baldwin CT, Barber RC, Barnes LL, Barral S, Beach TG, Becker JT, Beecham GW, Beekly D, Benitez BA, Bennett D, Bertelson J, Bird TD, Blacker D, Boeve BF, Bowen JD, Boxer A, Brewer J, Burke JR, Burns JM, Buxbaum JD, Cairns NJ, Cantwell LB, Cao C, Carlson CS, Carlsson CM, Carney RM, Carrasquillo MM, Chasse S, Chesselet MF, Chin NA, Chui HC, Chung J, Craft S, Crane PK, Cribbs DH, Crocco EA, Cruchaga C, Cuccaro ML, Cullum M, Darby E, Davis B, De Jager PL, DeCarli C, DeToledo J, Dick M, Dickson DW, Dombroski BA, Doody RS, Duara R, Ertekin-Taner N, Evans DA, Faber KM, Fairchild TJ, Fallon KB, Fardo DW, Farlow MR, Fernandez-Hernandez V, Ferris S, Foroud TM, Frosch MP, Fulton-Howard B, Galasko DR, Gamboa A, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Goate AM, Grabowski TJ, Graff-Radford NR, Green RC, Growdon JH, Hakonarson H, Hall J, Hamilton RL, Harari O, Hardy J, Harrell LE, Head E, Henderson VW, Hernandez M, Hohman T, Honig LS, Huebinger RM, Huentelman MJ, Hulette CM, Hyman BT, Hynan LS, Ibanez L, Jarvik GP, Jayadev S, Jin LW, Johnson K, Johnson L, Kamboh MI, Karydas AM, Katz MJ, Kauwe JS, Kaye JA, Keene CD, Khaleeq A, Kim R, Knebl J, Kowall NW, Kramer JH, Kukull WA, LaFerla FM, Lah JJ, Larson EB, Lerner A, Leverenz JB, Levey AI, Lieberman AP, Lipton RB, Logue M, Lopez OL, Lunetta KL, Lyketsos CG, Mains D, Margaret FE, Marson DC, Martin ERR, Martiniuk F, Mash DC, Masliah E, Massman P, Masurkar A, McCormick WC, McCurry SM, McDavid AN, McDonough S, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Montine TJ, Monuki ES, Morris JC, Mukherjee S, Myers AJ, Nguyen T, O'Bryant S, Olichney JM, Ory M, Palmer R, Parisi JE, Paulson HL, Pavlik V, Paydarfar D, Perez V, Peskind E, Petersen RC, Pierce A, Polk M, Poon WW, Potter H, Qu L, Quiceno M, Quinn JF, Raj A, Raskind M, Reiman EM, Reisberg B, Reisch JS, Ringman JM, Roberson ED, Rodriguear M, Rogaeva E, Rosen HJ, Rosenberg RN, Royall DR, Sager MA, Sano M, Saykin AJ, Schneider JA, Schneider LS, Seeley WW, Slifer SH, Small S, Smith AG, Smith JP, Sonnen JA, Spina S, St George-Hyslop P, Stern RA, Stevens AB, Strittmatter SM, Sultzer D, Swerdlow RH, Tanzi RE, Tilson JL, Trojanowski JQ, Troncoso JC, Tsuang DW, Van Deerlin VM, van Eldik LJ, Vance JM, Vardarajan BN, Vassar R, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Whitehead PL, Wijsman EM, Wilhelmsen KC, Williams B, Williamson J, Wilms H, Wingo TS, Wisniewski T, Woltjer RL, Woon M, Wright CB, Wu CK, Younkin SG, Yu CE, Yu L, Zhu X, Kunkle BW, Bush WS, Wang LS, Farrer LA, Haines JL, Mayeux R, Pericak-Vance MA, Schellenberg GD, Jun GR, Reitz C, Naj AC, Alzheimer's Disease Genetics Consortium. Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies LRRC4C, LHX5-AS1 and nominates ancestry-specific loci PTPRK , GRB14 , and KIAA0825 as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics Consortium. medRxiv, 2023. PMC10350126. DOI: 10.1101/2023.07.06.23292311\n\nReynolds C, Tan A, Elliott J, Tinsley C, Wall R, Kaye J, Silbert L, Lim M. Remote spectral light sensing in the home environment: Further development of the TWLITE study concept. Sensors, 2023. PMC10143576. DOI: 10.3390/s23084134\n\nSabbagh MN, Taylor A, Galasko D, Galvin JE, Goldman JG, Leverenz JB, Poston KL, Boeve BF, Irwin DJ, Quinn JF. Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panel. Alzheimers Dement (N Y) 9:e12375, 2023. PMC9983146. DOI: 10.1002/trc2.12375\n\nSadlon A, Takousis P, Ankli B, Alexopoulos P, Perneczky R, Alzheimer's Disease Neuroimaging Initiative. Association of chronic pain with biomarkers of neurodegeneration, microglial activation and inflammation in the CSF and impaired cognitive function. Annals of Neurology, 2023. DOI: 10.1002/ana.26804\n\nScott GD, Neilson LE, Woltjer R, Quinn JF, Lim MM. Lifelong Association of Disorders Related to Military Trauma with Subsequent Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society, 2023. DOI: 10.1002/mds.29457\n\nSepulveda-Falla D, Villegas Lanau CA, White C, Serrano GE, Acosta-Uribe J, Mejia-Cupajita B, Villalba-Moreno ND, Lu P, Glatzel M, Kofler JK, Ghetti B, Frosch MP, Lopera Restrepo F, Kosik KS, Beach TG. Comorbidities in Early-Onset Sporadic versus Presenilin-1 Mutation-Associated Alzheimer's Disease Dementia: Evidence for Dependency on Alzheimer's Disease Neuropathological Changes. medRxiv, 2023. PMC10462216. DOI: 10.1101/2023.08.14.23294081\n\nShinohara M, Gheni G, Hitomi J, Bu G, Sato N. APOE genotypes modify the obesity paradox in dementia. J Neurol Neurosurg Psychiatry 94:670-680, 2023. DOI: 10.1136/jnnp-2022-331034\n\nShirzadi Z, Schultz SA, Yau WW, Joseph-Mathurin N, Fitzpatrick CD, Levin R, Kantarci K, Preboske GM, Jack CR, Jr., Farlow MR, Hassenstab J, Jucker M, Morris JC, Xiong C, Karch CM, Levey AI, Gordon BA, Schofield PR, Salloway SP, Perrin RJ, McDade E, Levin J, Cruchaga C, Allegri RF, Fox NC, Goate A, Day GS, Koeppe R, Chui HC, Berman S, Mori H, Sanchez-Valle R, Lee JH, Rosa-Neto P, Ruthirakuhan M, Wu CY, Swardfager W, Benzinger TLS, Sohrabi HR, Martins RN, Bateman RJ, Johnson KA, Sperling RA, Greenberg SM, Schultz AP, Chhatwal JP, Dominantly Inherited Alzheimer Network, Alzheimer's Disease Neuroimaging Initiative. Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease. JAMA Neurol 80:1353-1363, 2023. DOI: 10.1001/jamaneurol.2023.3618\n\nSmith EE, Silbert LC. Myocardial Infarction Bends the Curve of Age-Related Cognitive Decline, but How? JAMA Neurol 80:665-667, 2023. DOI: 10.1001/jamaneurol.2023.0466\n\nSong S, Asken B, Armstrong MJ, Yang Y, Li Z, Alzheimer's Disease Neuroimaging I. Predicting Progression to Clinical Alzheimer's Disease Dementia Using the Random Survival Forest. Journal of Alzheimer's Disease 95:535-548, 2023. DOI: 10.3233/JAD-230208\n\nSperling RA, Donohue MC, Raman R, Rafii MS, Johnson K, Masters CL, van Dyck CH, Iwatsubo T, Marshall GA, Yaari R, Mancini M, Holdridge KC, Case M, Sims JR, Aisen PS, A4 Study Team. Trial of Solanezumab in Preclinical Alzheimer's Disease. N Engl J Med 389:1096-1107, 2023. DOI: 10.1056/NEJMoa2305032\n\nTagliabue CF, Bissig D, Kaye J, Mazza V, Assecondi S. Feasibility of Remote Unsupervised Cognitive Screening With SATURN in Older Adults. J Appl Gerontol 42:1903-1910, 2023. PMC in Process. DOI: 10.1177/07334648231166894\n\nTeipel S, Grothe MJ, Alzheimer's Disease Neuroimaging Initiative. MRI-based basal forebrain atrophy and volumetric signatures associated with limbic TDP-43 compared to Alzheimer's disease pathology. Neurobiol Dis 180:106070, 2023. DOI: 10.1016/j.nbd.2023.106070\n\nTing SKS, Saffari SE, Hameed S, Chiew HJ, Ng KP, Ng AS. Clinical characteristics of pathological confirmed prodromal dementia with Lewy bodies. J Neurol Sci 453:120815, 2023. PMC10591830. DOI: 10.1016/j.jns.2023.120815\n\nTorso M, Ridgway GR, Valotti M, Hardingham I, Chance SA, National Alzheimer’s Coordinating Center, Alzheimer’s Disease Neuroimaging Initiative. In vivo cortical diffusion imaging relates to Alzheimer's disease neuropathology. Alzheimers Res Ther 15:165, 2023. 10548768. DOI: 10.1186/s13195-023-01309-3\n\nTuena C, Maestri S, Serino S, Pedroli E, Stramba-Badiale M, Riva G, Alzheimer's Disease Neuroimaging Initiative. Prognostic relevance of gait-related cognitive functions for dementia conversion in amnestic mild cognitive impairment. BMC Geriatr 23:462, 2023. PMC10388514. DOI: 10.1186/s12877-023-04175-8\n\nTumurbaatar B, Fracassi A, Scaduto P, Guptarak J, Woltjer R, Jupiter D, Taglialatela G. Preserved autophagy in cognitively intact non-demented individuals with Alzheimer's neuropathology. Alzheimers Dement, 2023. DOI: 10.1002/alz.13074\n\nVasconcelos Da Silva M, Melendez-Torres GJ, Ismail Z, Testad I, Ballard C, Creese B, Alzheimer's Disease Neuroimaging Initiative. A data-driven examination of apathy and depressive symptoms in dementia with independent replication. Alzheimers Dement (Amst) 15:e12398, 2023. PMC9899765. DOI: 10.1002/dad2.12398\n\nVehar JV, Duff K, Rahimpour S, Dunn D, Ballard DJ, Zorn MS, Moretti P, Rolston J. The cognitive profile of essential tremor on the Repeatable Battery for the Assessment of Neuropsychological Status. Clin Neuropsychol:1-14, 2023. DOI: 10.1080/13854046.2023.2192420\n\nVehar JV, Rahimpour S, Moretti P, Kassavetis P, Alshaikh J, Rolston J, Duff K. Recognition subtests of the Repeatable Battery for the Assessment of Neuropsychological Status: evidence for a cortical vs. subcortical distinction. Journal of Clinical and Experimental Neuropsychology:1-12, 2023. DOI: 10.1080/13803395.2023.2259044\n\nWalker JM, Dehkordi SK, Schaffert J, Goette W, White Iii CL, Richardson TE, Zare H. The Spectrum of Alzheimer-Type Pathology in Cognitively Normal Individuals. Journal of Alzheimer's Disease 91:683-695, 2023. DOI: 10.3233/JAD-220898\n\nWalker JM, Richardson TE. Cognitive resistance to and resilience against multiple comorbid neurodegenerative pathologies and the impact of APOE status. Journal of Neuropathology and Experimental Neurology 82:110-119, 2023. PMC9852945. DOI: 10.1093/jnen/nlac115\n\nWalters S, Contreras AG, Eissman JM, Mukherjee S, Lee ML, Choi SE, Scollard P, Trittschuh EH, Mez JB, Bush WS, Kunkle BW, Naj AC, Peterson A, Gifford KA, Cuccaro ML, Cruchaga C, Pericak-Vance MA, Farrer LA, Wang LS, Haines JL, Jefferson AL, Kukull WA, Keene CD, Saykin AJ, Thompson PM, Martin ER, Bennett DA, Barnes LL, Schneider JA, Crane PK, Hohman TJ, Dumitrescu L, Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Genetics Consortium, Alzheimer's Disease Sequencing Project. Associations of Sex, Race, and Apolipoprotein E Alleles With Multiple Domains of Cognition Among Older Adults. JAMA Neurol, 2023. PMC10352930. DOI: 10.1001/jamaneurol.2023.2169\n\nWeiss AR, Urbanski HF. Effect of short-term androgen supplementation on cognitive performance in older male rhesus macaques. Neurobiol Aging. 2023 Dec;132:246-249. doi: 10.1016/j.neurobiolaging.2023.09.013. Epub 2023 Sep 27. PMID: 37866084. DOI: 10.1016/j.neurobiolaging.2023.09.013\n\nWiese LAK, Gibson A, Guest MA, Nelson AR, Weaver R, Gupta A, Carmichael O, Lewis JP, Lindauer A, Loi S, Peterson R, Radford K, Rhodus EK, Wong CG, Zuelsdorff M, Saidi LG, Valdivieso-Mora E, Franzen S, Pope CN, Killian TS, Shrestha HL, Heyn PC, Ng TKS, Prusaczyk B, John S, Kulshreshtha A, Sheffler JL, Besser L, Daniel V, Tolea MI, Miller J, Musyimi C, Corkey J, Yank V, Williams CL, Rahemi Z, Park J, Magzamen S, Newton RL, Jr., Harrington C, Flatt JD, Arora S, Walter S, Griffin P, Babulal GM. Global rural health disparities in Alzheimer's disease and related dementias: State of the science. Alzheimers Dement 19:4204-4225, 2023. DOI: 10.1002/alz.13104\n\nWood KA, Han F, Ko YA, Wharton WW. Is the association between cognitive disease progression and atrial fibrillation modified by sex? Alzheimers Dement 19:4163-4173, 2023. DOI: 10.1002/alz.13060\n\nWood ME, Xiong LY, Wong YY, Buckley RF, Swardfager W, Masellis M, Lim ASP, Nichols E, Joie R, Casaletto KB, Kumar RG, Dams-O'Connor K, Palta P, George KM, Satizabal CL, Barnes LL, Schneider JA, Binet AP, Villeneuve S, Pa J, Brickman AM, Black SE, Rabin JS. Sex differences in associations between APOE epsilon2 and longitudinal cognitive decline. Alzheimers Dement 19:4651-4661, 2023. PMC10544702. DOI: 10.1002/alz.13036\n\nWright KM, Bollen M, David J, Mepham B, Alcazar Magana A, McClure C, Maier CS, Quinn JF, Soumyanath A. Bioanalytical method validation and application to a phase 1, double-blind, randomized pharmacokinetic trial of a standardized Centella asiatica (L.) Urban water extract product in healthy older adults. Front Pharmacol 14:1228030, 2023. 10481538. DOI: 10.3389/fphar.2023.1228030\n\nWu C, Tibbitts D, Beattie Z, Dodge H, Shannon J, Kaye J, Winters-Stone K. Using Continuous Passive Assessment Technology to Describe Health and Behavior Patterns Preceding and Following a Cancer Diagnosis in Older Adults: Proof-of-Concept Case Series Study. JMIR Form Res 7:e45693, 2023. PMC10450537. DOI: 10.2196/45693\n\nXue Y, Xie X. The Association between Metformin Use and Risk of Developing Severe Dementia among AD Patients with Type 2 Diabetes. Biomedicines 11, 2023. PMC10669124. DOI: 10.3390/biomedicines11112935\n\nYi F, Yang H, Chen D, Qin Y, Han H, Cui J, Bai W, Ma Y, Zhang R, Yu H. XGBoost-SHAP-based interpretable diagnostic framework for alzheimer's disease. BMC Med Inform Decis Mak 23:137, 2023. PMC10369804. DOI: 10.1186/s12911-023-02238-9\n\nYuan F, Zhou W, Dodge HH, Zhao X. Short: Causal structural learning of conversational engagement for socially isolated older adults. Smart Health (Amst) 28, 2023. PMC10101035. DOI: 10.1016/j.smhl.2023.100384\n\nZhang Q, Fan C, Wang L, Li T, Wang M, Han Y, Jiang J, and for the Alzheimer's Disease Neuroimaging I. Glucose metabolism in posterior cingulate cortex has supplementary value to predict the progression of cognitively unimpaired to dementia due to Alzheimer's disease: an exploratory study of (18) F-FDG-PET. Geroscience, 2023. DOI: 10.1007/s11357-023-00897-0\n\nZheng L, Rubinski A, Dennecke J, Luan Y, Smith R, Strandberg O, Stomrud E, Ossenkoppele R, Svaldi DO, Higgins IA, Shcherbinin S, Pontecorvo MJ, Hansson O, Franzmeier N, Ewers M, Alzheimer's Disease Neuroimaging Initiative. Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer's Disease. Annals of Neurology, 2023. DOI: 10.1002/ana.26818\n\nZhou X, Chen Y, Ip F, Jiang Y, Cao H, Lv G, Zhong H, Chen J, Ye T, Chen Y, Zhang Y, Ma S, Lo RM, Tong E, Mok V, Kwok T, Guo Q, Mok K, Shoai M, Hardy J, Chen L, Fu A, Ip N, Alzheimer's Disease Neuroimaging Initiative. Deep learning-based polygenic risk analysis for Alzheimer's disease prediction. Commun Med (Lond) 3:49, 2023. PMC10079691. DOI: 10.1038/s43856-023-00269-x\n\nAnderson VC, Tagge IJ, Doud A, Li X, Springer CS, Jr., Quinn JF, Kaye JA, Wild KV, Rooney WD. DCE-MRI of Brain Fluid Barriers: In Vivo Water Cycling at the Human Choroid Plexus. Tissue Barriers 10:1963143, 2022. PMC879425. DOI: 10.1080/21688370.2021.1963143\n\nArnold MR, Coughlin DG, Brumbach BH, Smirnov DS, Concha-Marambio L, Farris CM, Ma Y, Inc A, Kim Y, Wilson EN, Kaye JA, Hiniker A, Woltjer RL, Galasko DR, Quinn JF. alpha-synuclein seed amplification in CSF and brain from patients with different brain distributions of pathological alpha-synuclein in the context of co-pathology and non-LBD diagnoses. Annals of Neurology 92:650-662, 2022. PMC in Process. DOI: 10.1002/ana.26453\n\nAu-Yeung WM, Miller L, Beattie Z, May R, Cray HV, Kabelac Z, Katabi D, Kaye J, Vahia IV. Monitoring Behaviors of Patients With Late-Stage Dementia Using Passive Environmental Sensing Approaches: A Case Series. Am J Geriatr Psychiatry 30:1-11, 2022. PMC8531172. DOI: 10.1016/j.jagp.2021.04.008\n\nBabulal GM, Zhu Y, Roe CM, Hudson DL, Williams MM, Murphy SA, Doherty J, Johnson AM, Trani JF. The complex relationship between depression and progression to incident cognitive impairment across race and ethnicity. Alzheimers Dement 18:2593-2602, 2022. PMC9402798. DOI: 10.1002/alz.12631\n\nBarker MS, Gottesman RT, Manoochehri M, Chapman S, Appleby BS, Brushaber D, Devick KL, Dickerson BC, Domoto-Reilly K, Fields JA, Forsberg LK, Galasko DR, Ghoshal N, Goldman J, Graff-Radford NR, Grossman M, Heuer HW, Hsiung GY, Knopman DS, Kornak J, Litvan I, Mackenzie IR, Masdeu JC, Mendez MF, Pascual B, Staffaroni AM, Tartaglia MC, Boeve BF, Boxer AL, Rosen HJ, Rankin KP, Cosentino S, Rascovsky K, Huey ED, ALLFTD Consortium. Proposed research criteria for prodromal behavioural variant frontotemporal dementia. Brain 145:1079-1097, 2022. PMC9050566. DOI: 10.1093/brain/awab365\n\nBellenguez C, Kucukali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, Naj AC, Campos-Martin R, Grenier-Boley B, Andrade V, Holmans PA, Boland A, Damotte V, van der Lee SJ, Costa MR, Kuulasmaa T, Yang Q, de Rojas I, Bis JC, Yaqub A, Prokic I, Chapuis J, Ahmad S, Giedraitis V, Aarsland D, Garcia-Gonzalez P, Abdelnour C, Alarcon-Martin E, Alcolea D, Alegret M, Alvarez I, Alvarez V, Armstrong NJ, Tsolaki A, Antunez C, Appollonio I, Arcaro M, Archetti S, Pastor AA, Arosio B, Athanasiu L, Bailly H, Banaj N, Baquero M, Barral S, Beiser A, Pastor AB, Below JE, Benchek P, Benussi L, Berr C, Besse C, Bessi V, Binetti G, Bizarro A, Blesa R, Boada M, Boerwinkle E, Borroni B, Boschi S, Bossu P, Brathen G, Bressler J, Bresner C, Brodaty H, Brookes KJ, Brusco LI, Buiza-Rueda D, Burger K, Burholt V, Bush WS, Calero M, Cantwell LB, Chene G, Chung J, Cuccaro ML, Carracedo A, Cecchetti R, Cervera-Carles L, Charbonnier C, Chen HH, Chillotti C, Ciccone S, Claassen J, Clark C, Conti E, Corma-Gomez A, Costantini E, Custodero C, Daian D, Dalmasso MC, Daniele A, Dardiotis E, Dartigues JF, de Deyn PP, de Paiva Lopes K, de Witte LD, Debette S, Deckert J, Del Ser T, Denning N, DeStefano A, Dichgans M, Diehl-Schmid J, Diez-Fairen M, Rossi PD, Djurovic S, Duron E, Duzel E, Dufouil C, Eiriksdottir G, Engelborghs S, Escott-Price V, Espinosa A, Ewers M, Faber KM, Fabrizio T, Nielsen SF, Fardo DW, Farotti L, Fenoglio C, Fernandez-Fuertes M, Ferrari R, Ferreira CB, Ferri E, Fin B, Fischer P, Fladby T, Fliessbach K, Fongang B, Fornage M, Fortea J, Foroud TM, Fostinelli S, Fox NC, Franco-Macias E, Bullido MJ, Frank-Garcia A, Froelich L, Fulton-Howard B, Galimberti D, Garcia-Alberca JM, Garcia-Gonzalez P, Garcia-Madrona S, Garcia-Ribas G, Ghidoni R, Giegling I, Giorgio G, Goate AM, Goldhardt O, Gomez-Fonseca D, Gonzalez-Perez A, Graff C, Grande G, Green E, Grimmer T, Grunblatt E, Grunin M, Gudnason V, Guetta-Baranes T, Haapasalo A, Hadjigeorgiou G, Haines JL, Hamilton-Nelson KL, Hampel H, Hanon O, Hardy J, Hartmann AM, Hausner L, Harwood J, Heilmann-Heimbach S, Helisalmi S, Heneka MT, Hernandez I, Herrmann MJ, Hoffmann P, Holmes C, Holstege H, Vilas RH, Hulsman M, Humphrey J, Biessels GJ, Jian X, Johansson C, Jun GR, Kastumata Y, Kauwe J, Kehoe PG, Kilander L, Stahlbom AK, Kivipelto M, Koivisto A, Kornhuber J, Kosmidis MH, Kukull WA, Kuksa PP, Kunkle BW, Kuzma AB, Lage C, Laukka EJ, Launer L, Lauria A, Lee CY, Lehtisalo J, Lerch O, Lleo A, Longstreth W, Jr., Lopez O, de Munain AL, Love S, Lowemark M, Luckcuck L, Lunetta KL, Ma Y, Macias J, MacLeod CA, Maier W, Mangialasche F, Spallazzi M, Marquie M, Marshall R, Martin ER, Montes AM, Rodriguez CM, Masullo C, Mayeux R, Mead S, Mecocci P, Medina M, Meggy A, Mehrabian S, Mendoza S, Menendez-Gonzalez M, Mir P, Moebus S, Mol M, Molina-Porcel L, Montrreal L, Morelli L, Moreno F, Morgan K, Mosley T, Nothen MM, Muchnik C, Mukherjee S, Nacmias B, Ngandu T, Nicolas G, Nordestgaard BG, Olaso R, Orellana A, Orsini M, Ortega G, Padovani A, Paolo C, Papenberg G, Parnetti L, Pasquier F, Pastor P, Peloso G, Perez-Cordon A, Perez-Tur J, Pericard P, Peters O, Pijnenburg YAL, Pineda JA, Pinol-Ripoll G, Pisanu C, Polak T, Popp J, Posthuma D, Priller J, Puerta R, Quenez O, Quintela I, Thomassen JQ, Rabano A, Rainero I, Rajabli F, Ramakers I, Real LM, Reinders MJT, Reitz C, Reyes-Dumeyer D, Ridge P, Riedel-Heller S, Riederer P, Roberto N, Rodriguez-Rodriguez E, Rongve A, Allende IR, Rosende-Roca M, Royo JL, Rubino E, Rujescu D, Saez ME, Sakka P, Saltvedt I, Sanabria A, Sanchez-Arjona MB, Sanchez-Garcia F, Juan PS, Sanchez-Valle R, Sando SB, Sarnowski C, Satizabal CL, Scamosci M, Scarmeas N, Scarpini E, Scheltens P, Scherbaum N, Scherer M, Schmid M, Schneider A, Schott JM, Selbaek G, Seripa D, Serrano M, Sha J, Shadrin AA, Skrobot O, Slifer S, Snijders GJL, Soininen H, Solfrizzi V, Solomon A, Song Y, Sorbi S, Sotolongo-Grau O, Spalletta G, Spottke A, Squassina A, Stordal E, Tartan JP, Tarraga L, Tesi N, Thalamuthu A, Thomas T, Tosto G, Traykov L, Tremolizzo L, Tybjaerg-Hansen A, Uitterlinden A, Ullgren A, Ulstein I, Valero S, Valladares O, Broeckhoven CV, Vance J, Vardarajan BN, van der Lugt A, Dongen JV, van Rooij J, van Swieten J, Vandenberghe R, Verhey F, Vidal JS, Vogelgsang J, Vyhnalek M, Wagner M, Wallon D, Wang LS, Wang R, Weinhold L, Wiltfang J, Windle G, Woods B, Yannakoulia M, Zare H, Zhao Y, Zhang X, Zhu C, Zulaica M, Farrer LA, Psaty BM, Ghanbari M, Raj T, Sachdev P, Mather K, Jessen F, Ikram MA, de Mendonca A, Hort J, Tsolaki M, Pericak-Vance MA, Amouyel P, Williams J, Frikke-Schmidt R, Clarimon J, Deleuze JF, Rossi G, Seshadri S, Andreassen OA, Ingelsson M, Hiltunen M, Sleegers K, Schellenberg GD, van Duijn CM, Sims R, van der Flier WM, Ruiz A, Ramirez A, Lambert JC. New insights into the genetic etiology of Alzheimer's disease and related dementias. Nature Genetics, 2022. DOI: 10.1038/s41588-022-01024-z\n\nBelloy ME, Eger SJ, Le Guen Y, Damotte V, Ahmad S, Ikram MA, Ramirez A, Tsolaki AC, Rossi G, Jansen IE, de Rojas I, Parveen K, Sleegers K, Ingelsson M, Hiltunen M, Amin N, Andreassen O, Sanchez-Juan P, Kehoe P, Amouyel P, Sims R, Frikke-Schmidt R, van der Flier WM, Lambert JC, He Z, Han SS, Napolioni V, Greicius MD. Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping. Alzheimers Res Ther 14:22, 2022. PMC8815198. DOI: 10.1186/s13195-022-00962-4\n\nBenge JF, Artz JD, Kiselica AM. The ecological validity of the Uniform Data Set 3.0 neuropsychological battery in individuals with mild cognitive impairment and dementia. Clin Neuropsychol 36:1453-1470, 2022. PMC8071839. DOI: 10.1080/13854046.2020.1837246\n\nBernstein JP, Mattek N, Dorociak KE, Beattie ZT, Kaye JA, Ferguson JE, Hughes AM. Age Predicts Older Adults’ Driving Self-Regulation but Not Dangerous Driving Behaviors after Controlling for Executive Function. Gerontology 68:98-105, 2022. DOI: 10.1159/000515497\n\nBernstein JPK, Dorociak K, Mattek N, Leese M, Trapp C, Beattie Z, Kaye J, Hughes A. Unobtrusive, in-home assessment of older adults' everyday activities and health events: associations with cognitive performance over a brief observation period. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 29:781-798, 2022. PMC8522171. DOI: 10.1080/13825585.2021.1917503\n\nBerridge C, Zhou Y, Lazar A, Porwal A, Mattek N, Gothard S, Kaye J. Control Matters in Elder Care Technology: Evidence and Direction for Designing It In. In: ACM, ed. Designing Interactive Systems Conference,. Australia, 2022: 1831-1848. DOI: 10.1145/3532106.3533471\n\nBreitner J, Dodge H, Khachaturian ZS, Khachaturian A. Exceptions that prove the rule–Why have clinical trials failed to show efficacy of risk factor interventions suggested by observational studies of the dementia-Alzheimer's disease syndrome? Alzheimer's Dement 18:389-392, 2022. PMC8940699. DOI: 10.1002/alz.12633\n\nBuckles VD, Xiong C, Bateman RJ, Hassenstab J, Allegri R, Berman SB, Chhatwal JP, Danek A, Fagan AM, Ghetti B, Goate A, Graff-Radford N, Jucker M, Levin J, Marcus DS, Masters CL, McCue L, McDade E, Mori H, Moulder KL, Noble JM, Paumier K, Preische O, Ringman JM, Fox NC, Salloway S, Schofield PR, Martins R, Voglein J, Morris JC. Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer disease. Alzheimers Dement 18:1754-1764, 2022. PMC9160203. DOI: 10.1002/alz.12505\n\nCothran FA, Alto R, Tomaszewski Farias S, Johnson DK, Lara E, Whitmer RA, DeCarli C, Meyer OL. Caring for the Caregivers: An Alzheimer Disease Research Center Call to Action. Alzheimer Disease and Associated Disorders 36:92-95, 2022. DOI: 10.1097/WAD.0000000000000483\n\nDawson W, et al. Build Back Brainier: Base Policies on Brain Science. In: Hynes W, Linkov I, Love P, eds. A Systemic Recovery, New Approaches to Economic Challenges. Paris: OECD Publishing, 2022.\n\nDawson W, Smith E, Booi L, Mosse M, Lavretsky H, Reynolds C, Cummings J, Brannelly P, Hynes W, Lenze E, Manes F, Ayadi R, Frank L, Chapman S, Robertson I, Rubenstein L, Jraissati J, Ibáñez A, Fillit H, Jeste D, Rao A, Berk M, Storch E, Chadha A, Eyre H. Investing in Late-Life Brain Capital. Innovation in Aging 6:2022, 2022. DOI: 10.1093/geroni/igac016\n\nDissanayake AS, Tan YB, Bowie CR, Butters MA, Flint AJ, Gallagher D, Golas AC, Herrmann N, Ismail Z, Kennedy JL, Kumar S, Lanctot KL, Mah L, Mulsant BH, Pollock BG, Rajji TK, Tau M, Maraj A, Churchill NW, Tsuang D, Schweizer TA, Munoz DG, Fischer CE, Group PA-MS. Sex Modifies the Associations of APOEvarepsilon4 with Neuropsychiatric Symptom Burden in Both At-Risk and Clinical Cohorts of Alzheimer's Disease. Journal of Alzheimer's Disease 90:1571-1588, 2022. DOI: 10.3233/JAD-220586\n\nDuong MT, Das SR, Lyu X, Xie L, Richardson H, Xie SX, Yushkevich PA, Wolk DA, Nasrallah IM, Alzheimer’s Disease Neuroimaging Initiative (ADNI). Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer's disease. Nat Commun 13:1495, 2022. DOI: 10.1038/s41467-022-28941-1\n\nElliott JE, Tinsley CE, Reynolds C, Olson RJ, Weymann KB, Au-Yeung WM, Wilkerson A, Kaye JA, Lim MM. Tunable White Light for Elders (TWLITE): A Protocol Demonstrating Feasibility and Acceptability for Deployment, Remote Data Collection, and Analysis of a Home-Based Lighting Intervention in Older Adults. Sensors (Basel) 22, 2022. PMC9320387. DOI: 10.3390/s22145372\n\nFarrell K, Kim S, Han N, Iida MA, Gonzalez EM, Otero-Garcia M, Walker JM, Richardson TE, Renton AE, Andrews SJ, Fulton-Howard B, Humphrey J, Vialle RA, Bowles KR, de Paiva Lopes K, Whitney K, Dangoor DK, Walsh H, Marcora E, Hefti MM, Casella A, Sissoko CT, Kapoor M, Novikova G, Udine E, Wong G, Tang W, Bhangale T, Hunkapiller J, Ayalon G, Graham RR, Cherry JD, Cortes EP, Borukov VY, McKee AC, Stein TD, Vonsattel JP, Teich AF, Gearing M, Glass J, Troncoso JC, Frosch MP, Hyman BT, Dickson DW, Murray ME, Attems J, Flanagan ME, Mao Q, Mesulam MM, Weintraub S, Woltjer RL, Pham T, Kofler J, Schneider JA, Yu L, Purohit DP, Haroutunian V, Hof PR, Gandy S, Sano M, Beach TG, Poon W, Kawas CH, Corrada MM, Rissman RA, Metcalf J, Shuldberg S, Salehi B, Nelson PT, Trojanowski JQ, Lee EB, Wolk DA, McMillan CT, Keene CD, Latimer CS, Montine TJ, Kovacs GG, Lutz MI, Fischer P, Perrin RJ, Cairns NJ, Franklin EE, Cohen HT, Raj T, Cobos I, Frost B, Goate A, White Iii CL, Crary JF. Genome-wide association study and functional validation implicates JADE1 in tauopathy. Acta Neuropathol 143:33-53, 2022. PMC8786260. DOI: 10.1007/s00401-021-02379-z\n\nFracassi A, Marcatti M, Tumurbaatar B, Woltjer R, Moreno S, Taglialatela G. TREM2-induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer's neuropathology. Brain Pathology:e13108, 2022. DOI: 10.1111/bpa.13108\n\nGabel M, Bollinger RM, Coble DW, Grill JD, Edwards DF, Lingler JH, Chin E, Stark SL. Retaining Participants in Longitudinal Studies of Alzheimer's Disease. Journal of Alzheimer's Disease 87:945-955, 2022. DOI: 10.3233/JAD-215710\n\nGalvin-McLaughlin D, Klee D, Memmott T, Peters B, Wiedrick J, Fried-Oken M, Oken B, Consortium for Accessible Multimodal Brain-Body Interfaces (CAMBI). Methodology and Preliminary Data on Feasibility of a Neurofeedback Protocol to Improve Visual Attention to Letters in Mild Alzheimer’s Disease. Contemporary Clinical Trials 28:100950, 2022. PMC9228283. DOI: 10.1016/j.conctc.2022.100950\n\nGodrich D, Martin ER, Schellenberg G, Pericak-Vance MA, Cuccaro M, Scott WK, Kukull W, Montine T, Beecham GW. Neuropathological lesions and their contribution to dementia and cognitive impairment in a heterogeneous clinical population. Alzheimers Dement 18:2403-2412, 2022. PMC9360193. DOI: 10.1002/alz.12516\n\nGonzalez DA, Gonzales MM, Resch ZJ, Sullivan AC, Soble JR. Comprehensive Evaluation of the Functional Activities Questionnaire (FAQ) and Its Reliability and Validity. Assessment 29:748-763, 2022. PMC8339133. DOI: 10.1177/1073191121991215\n\nGonzalez DA, Resch ZJ, Gonzales MM, Soble JR. A Novel Method for Establishing Functional Change in Older Adults With Cognitive Impairment. Alzheimer Disease and Associated Disorders 36:238-243, 2022. PMC9420747. DOI: 10.1097/WAD.0000000000000507\n\nGraves LV, Edmonds EC, Thomas KR, Weigand AJ, Cooper S, Stickel AM, Zlatar ZZ, Clark AL, Bondi MW. Diagnostic accuracy and differential associations between ratings of functioning and neuropsychological performance in non-Hispanic Black and White older adults. Clin Neuropsychol 36:287-310, 2022. PMC8849565. DOI: 10.1080/13854046.2021.1971766\n\nHeath L, Earls JC, Magis AT, Kornilov SA, Lovejoy JC, Funk CC, Rappaport N, Logsdon BA, Mangravite LM, Kunkle BW, Martin ER, Naj AC, Ertekin-Taner N, Golde TE, Hood L, Price ND. Alzheimer’s Disease Genetics Consortium. Manifestations of Alzheimer's disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90. Sci Rep 12:6117, 2022. PMC9005657. DOI: 10.1038/s41598-022-09825-2\n\nHepburn K, Nocera J, Higgins M, Epps F, Brewster GS, Lindauer A, Morhardt D, Shah R, Bonds K, Nash R, Griffiths PC. Results of a Randomized Trial Testing the Efficacy of Tele-Savvy, an Online Synchronous/Asynchronous Psychoeducation Program for Family Caregivers of Persons Living with Dementia. Gerontologist 62:616-628, 2022. PMC7989248. DOI: 10.1093/geront/gnab029\n\nHong Y, Zeng X, Zhu CW, Neugroschl J, Aloysi A, Sano M, Li C. Evaluating the Beijing Version of Montreal Cognitive Assessment for Identification of Cognitive Impairment in Monolingual Chinese American Older Adults. Journal of Geriatric Psychiatry and Neurology 35:586-593, 2022. PMC8831672. DOI: 10.1177/08919887211036182\n\nHupfeld KE, Richmond SB, McGregor HR, Schwartz DL, Luther MN, Beltran NE, Kofman IS, De Dios YE, Riascos RF, Wood SJ, Bloomberg JJ, Mulavara AP, Silbert LC, Iliff JJ, Seidler RD, Piantino J. Longitudinal MRI-visible perivascular space (PVS) changes with long-duration spaceflight. Sci Rep 12:7238, 2022. PMC072425.\n\nHwangbo N, Zhang X, Raftery D, Gu H, Hu SC, Montine TJ, Quinn JF, Chung KA, Hiller AL, Wang D, Fei Q, Bettcher L, Zabetian CP, Peskind E, Li G, Promislow DEL, Franks A. A Metabolomic Aging Clock Using Human Cerebrospinal Fluid. J Gerontol A Biol Sci Med Sci 77:744-754, 2022. PMC8974344. DOI: 10.1038/s41598-022-11593-y\n\nHwangbo N, Zhang X, Raftery D, Gu H, Hu SC, Montine TJ, Quinn JF, Chung KA, Hiller AL, Wang D, Fei Q, Bettcher L, Zabetian CP, Peskind ER, Li G, Promislow DEL, Davis MY, Franks A. Predictive Modeling of Alzheimer's and Parkinson's Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal Fluid. Metabolites 12:277, 2022. PMC9029812. DOI: 10.3390/metabo12040277]\n\nInglese M, Patel N, Linton-Reid K, Loreto F, Win Z, Perry RJ, Carswell C, Grech-Sollars M, Crum WR, Lu H, Malhotra PA, Aboagye EO. Alzheimer’s Disease Neuroimaging Initiative. A predictive model using the mesoscopic architecture of the living brain to detect Alzheimer's disease. Commun Med (Lond) 2:70, 2022. PMC9209493. DOI: 10.1038/s43856-022-00133-4\n\nJiang J, Sheng C, Chen G, Liu C, Jin S, Li L, Jiang X, Han Y, Alzheimer's Disease Neuroimaging Initiative. Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment. Geroscience 44:2319-2336, 2022. PMC9616982. DOI: 10.1007/s11357-022-00588-2\n\nJicha GA, Abner EL, Arnold SE, Carrillo MC, Dodge HH, Edland SD, Fargo KN, Feldman HH, Goldstein LB, Hendrix J, Peters R, Robillard JM, Schneider LS, Titiner JR, Weber CJ. Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus report. Alzheimers Dement 18:1109-1118, 2022. PMC8960469. DOI: 10.1002/alz.12461\n\nJin B, Capra JA, Benchek P, Wheeler N, Naj AC, Hamilton-Nelson KL, Farrell JJ, Leung YY, Kunkle B, Vadarajan B, Schellenberg GD, Mayeux R, Wang LS, Farrer LA, Pericak-Vance MA, Martin ER, Haines JL, Crawford DC, Bush WS. An association test of the spatial distribution of rare missense variants within protein structures identifies Alzheimer's disease-related patterns. Genome Res 32:778-790, 2022. PMC8997344. DOI: 10.1101/gr.276069.121\n\nJohnson EEH, Alexander C, Lee GJ, Angers K, Ndiaye D, Suhr J. Examination of race and gender differences in predictors of neuropsychological decline and development of Alzheimer's disease. Clin Neuropsychol 36:327-352, 2022. DOI: 10.1080/13854046.2021.1940299\n\nJun GR, You Y, Zhu C, Meng G, Chung J, Panitch R, Hu J, Xia W, Alzheimer's Disease Genetics C, Bennett DA, Foroud TM, Wang LS, Haines JL, Mayeux R, Pericak-Vance MA, Schellenberg GD, Au R, Lunetta KL, Ikezu T, Stein TD, Farrer LA, Alzheimer's Disease Genetics Consortium. Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE varepsilon2 for Alzheimer's disease. Alzheimers Dement 18:2042-2054, 2022. PMC9360190. DOI: 10.1002/alz.12607\n\nKatsumata Y, Shade LM, Hohman TJ, Schneider JA, Bennett DA, Farfel JM, Alzheimer's Disease Genetics C, Kukull WA, Fardo DW, Nelson PT. Multiple gene variants linked to Alzheimer's-type clinical dementia via GWAS are also associated with non-Alzheimer's neuropathologic entities. Neurobiol Dis 174:\"105880\", 2022. DOI: 10.1016/j.nbd.2022.105880\n\nKim H, Senders A, Simeon E, Juarez C, Huang S, Dodge H, McConnell KJ. Use of long-term services and supports among dual-eligible beneficiaries with Alzheimer's disease and related dementias. Journal of the American Geriatrics Society, 2022. DOI: 10.1111/jgs.18115\n\nKondo T, Hara N, Koyama S, Yada Y, Tsukita K, Nagahashi A, Ikeuchi T, Ishii K, Asada T, Arai T, Yamada R, Alzheimer's Disease Neuroimaging Initiative, Japanese Alzheimer's Disease Neuroimaging Initiative, Inoue H. Dissection of the polygenic architecture of neuronal Abeta production using a large sample of individual iPSC lines derived from Alzheimer's disease patients. Nat Aging 2:125-139, 2022. DOI: 10.1038/s43587-021-00158-9\n\nKundu P, Zimmerman B, Quinn JF, Kaye J, Mattek N, Westaway SK, Raber J. Serum Levels of alpha-Klotho Are Correlated with Cerebrospinal Fluid Levels and Predict Measures of Cognitive Function. Journal of Alzheimer's Disease, 2022. DOI: 10.3233/JAD-215719\n\nLahna D, Roese N, Woltjer R, Boespflug E, Schwartz D, Grinstead J, Dodge H, Wall R, Kaye J, Rooney W, Silbert L. Postmortem 7T MRI for Guided Histopathology and Evaluation of Cerebrovascular Disease. Journal of Neuropathology & Experimental Neurology 82:57-70, 2022. PMC9764082. DOI: 10.1093/jnen/nlac103\n\nLahna D, Schwartz DL, Woltjer R, Black SE, Roese N, Dodge H, Boespflug EL, Keith J, Gao F, Ramirez J, Silbert LC. Venous Collagenosis as Pathogenesis of White Matter Hyperintensity. Annals of Neurology, 2022. DOI: 10.1002/ana.26487\n\nLan G, Cai Y, Li A, Liu Z, Ma S, Guo T, Alzheimer's Disease Neuroimaging Initiative. Association of presynaptic loss with Alzheimer's disease and cognitive decline. Annals of Neurology, 2022. DOI: 10.1002/ana.26492\n\nLeese M, Mattek N, Bernstein J, Dorociak K, Gothard S, Kaye J, Seelye A. The Survey for Memory, Attention, and Reaction Time (SMART): Preliminary Normative Online Panel Data and User Attitudes for a Brief Web-Based Cognitive Performance Measure. The Clinical Neuropsychologist 5:1-19, 2022. DOI: 10.1080/13854046.2022.2103033\n\nLennon JC, Aita SL, Bene V, Rhoads T, Resch ZJ, Eloi JM, Walker KA. Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation. Alzheimers Dement 18:1461-1471, 2022. PMC9160212. DOI: 10.1002/alz.12509\n\nLiew TM. Subjective cognitive decline, APOE e4 allele, and the risk of neurocognitive disorders: Age- and sex-stratified cohort study. Aust N Z J Psychiatry 56:1664-1675, 2022. PMC9433458. DOI: 10.1177/00048674221079217\n\nLilly C, Wang Z, Dunlap D, Kaye J, Gohtard S, Teebagy S, Hafer N, Rogers E, Buchholz B, McManus D. 2021 Patient Preferences for Point of Care Testing Survey: More Acceptance and Less Concern. J Appl Lab Med, 2022. DOI: 10.1093/jalm/jfac070\n\nLindauer A, Wild K, Natonson A, Mattek N, Wolf M, Steeves-Reece A, Messecar D. Dementia 360 ECHO: Using technology to facilitate diagnosis and treatment. Gerontol Geriatr Educ 43:202-208, 2022. PMC8581834. DOI: 10.1080/02701960.2020.1835658\n\nLiu H, Lutz M, Luo S, Alzheimer's Disease Neuroimaging Initiative. Genetic Association Between Epigenetic Aging-Acceleration and the Progression of Mild Cognitive Impairment to Alzheimer's Disease. J Gerontol A Biol Sci Med Sci 77:1734-1742, 2022. PMC9434458. DOI: 10.1093/gerona/glac138\n\nLutz MW, Khachaturian AS, Zetterberg H, Blennow K, Willette AA, Mielke MM, Hayden KM, Dodge HH, Tang Y, Greenberg BD, Kukull WA, Khachaturian ZS. Biomarkers of Alzheimer syndrome and related dementias: A&D author's guide. Alzheimers Dement 18:1595-1601, 2022. DOI: 10.1002/alz.12772\n\nMcDonough IM, Cody SL, Harrell ER, Garrett SL, Popp TE. Cognitive differences across ethnoracial category, socioeconomic status across the Alzheimer's disease spectrum: Can an ability discrepancy score level the playing field? Mem Cognit, 2022. DOI: 10.3758/s13421-022-01304-3\n\nMcGirr A, Nathan S, Ghahremani M, Gill S, Smith EE, Ismail Z. Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms. Neurology 98:e2132-e2139, 2022. DOI: 10.1212/WNL.0000000000200256\n\nMilicic L, Vacher M, Porter T, Dore V, Burnham SC, Bourgeat P, Shishegar R, Doecke J, Armstrong NJ, Tankard R, Maruff P, Masters CL, Rowe CC, Villemagne VL, Laws SM, Alzheimer’s Disease Neuroimaging Initiative. Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume. Geroscience 44:1807-1823, 2022. PMC9213584. DOI: 10.1007/s11357-022-00558-8\n\nMilicic L, Vacher M, Porter T, Dore V, Burnham SC, Bourgeat P, Shishegar R, Doecke J, Armstrong NJ, Tankard R, Maruff P, Masters CL, Rowe CC, Villemagne VL, Laws SM, Alzheimer’s Disease Neuroimaging Initiative (ADNI, Australian Imaging Biomarkers and Lifestyle (AIBL) Study. Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume. Geroscience, 2022. DOI: 10.1007/s11357-022-00558-8\n\nMiller LM, Solomon DN, Whitlatch CJ, Hiatt SO, Wu CY, Reynolds C, Au-Yeung WM, Kaye J, Steele JS. The Remote Assessment and Dynamic Response Program: Development of an In-Home Dementia-Related Care Needs Assessment to Improve Well-Being. Innov Aging 6:igac006, 2022. PMC8985764. DOI: 10.1093/geroni/igac006\n\nMiller LM, Steele JS, Wu CY, Kaye J, Dodge HH, Gonzales MM, Lyons KS. Depressive symptoms in older adult couples: Associations with dyadic physical health, social engagement, and close friends. Front Psychiatry 13:989182, 2022. PMC9513127. DOI: 10.3389/fpsyt.2022.98918260. Morrow CB, Leoutsakos JS, Onyike CU. Functional Disabilities and Psychiatric Symptoms in Primary Progressive Aphasia. Am J Geriatr Psychiatry 30:372-382, 2022. DOI: 10.1016/j.jagp.2021.07.013\n\nMoses J, Sinclair B, Schwartz D, Silbert L, O’Brien T, Law M, Vivash L. Perivascular spaces as a marker of disease severity and neurodegeneration in patients with behavioral variant frontotemporal dementia. Frontiers in Neuroscience 16:1003522, 2022. PMC9633276. DOI: 10.3389/fnins.2022.1003522\n\nNeupane A, Lenny B, Budde JP, Wang F, Norton J, Morris JC, Cruchaga C, Fernandez MV. Replication study of AD-associated rare variants. Alzheimers Dement 18:858-862, 2022. PMC8986593. DOI: 10.1002/alz.12583\n\nNunnerley M, Kaye J, Beattie Z, Mattek N. Preferences of NIA Alzheimer’s Disease Research Center Participants Regarding Remote Assessment During the COVID-19 Pandemic. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2022:e12373, 2022. PMC9677364. DOI: 10.1002/dad2.12373\n\nPage ML, Vance EL, Cloward ME, Ringger E, Dayton L, Ebbert MTW, Miller JB, Kauwe JSK, Alzheimer's Disease Neuroimaging initiative. The Polygenic Risk Score Knowledge Base offers a centralized online repository for calculating and contextualizing polygenic risk scores. Commun Biol 5:899, 2022. DOI: 10.1038/s42003-022-03795-x\n\nPeters R, Dodge HH, James S, Jicha GA, Meyer PF, Richards M, Smith AD, Yassine HN, Abner E, Hainsworth AH. The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here? Alzheimer's & Dementia 18:507-512, 2022. DOI: 10.1002/alz.12393\n\nPichet Binette A, Franzmeier N, Spotorno N, Ewers M, Brendel M, Biel D, Strandberg O, Janelidze S, Palmqvist S, Mattsson-Carlgren N, Smith R, Stomrud E, Ossenkoppele R, Hansson O. Alzheimer’s Disease Neuroimaging Initiative. Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer's disease. Nat Commun 13:6635, 2022. PMC9636262. DOI: 10.1038/s41467-022-34129-4\n\nPillai JA, Bena J, Rothenberg K, Boron B, Leverenz JB. Association of Variation in Behavioral Symptoms With Initial Cognitive Phenotype in Adults With Dementia Confirmed by Neuropathology. JAMA Netw Open 5:e220729, 2022. PMC8895258. DOI: 10.1001/jamanetworkopen.2022.0729\n\nQiu J, Goldstein FC, Hanfelt JJ. An Exploration of Subgroups of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Risks of Conversion to Dementia or Death. Am J Geriatr Psychiatry 30:925-934, 2022. PMC9250542. DOI: 10.1016/j.jagp.2021.12.016\n\nQuinn JF, Kelly MJ, Harris CJ, Hack W, Gray NE, Kulik V, Bostick Z, Brumbach BH, Copenhaver PF. The novel estrogen modulator STX attenuates Amyloid-beta neurotoxicity in the 5XFAD mouse model of Alzheimer's disease. Neurobiol Dis:105888, 2022. DOI: 10.1016/j.nbd.2022.105888\n\nQuinones AR, Chen S, Nagel CL, Botoseneanu A, Allore HG, Newsom JT, Thielke S, Kaye J. Trajectories of cognitive functioning in later life: Disparities by race/ethnicity, educational attainment, sex, and multimorbidity combinations. SSM Popul Health 18:101084, 2022. PMC8987641. DOI: 10.1016/j.ssmph.2022.101084\n\nQuinones AR, Nagel CL, Botoseneanu A, Newsom JT, Dorr DA, Kaye J, Thielke SM, Allore HG. Multidimensional trajectories of multimorbidity, functional status, cognitive performance, and depressive symptoms among diverse groups of older adults. J Multimorb Comorb 12:26335565221143012, 2022. PMC9720836. DOI: 10.1177/26335565221143012\n\nReynolds C, Mattek N, Lim MM, Beattie Z, Dodge HH, Kaye J. Association Between Mild Cognitive Impairment and Seasonal Rest-Activity Patterns of Older Adults. Front Digit Health 4:809370, 2022. PMC8904352. DOI: 10.3389/fdgth.2022.809370\n\nRuthirakuhan M, Ismail Z, Herrmann N, Gallagher D, Lanctot KL. Mild behavioral impairment is associated with progression to Alzheimer's disease: A clinicopathological study. Alzheimers Dement 18:2199-2208, 2022. PMC9339594. DOI: 10.1002/alz.12519\n\nSandau US, McFarland TJ, Smith SJ, Galasko DR, Quinn JF, Saugstad JA. Differential Effects of APOE Genotype on MicroRNA Cargo of Cerebrospinal Fluid Extracellular Vesicles in Females With Alzheimer's Disease Compared to Males. Front Cell Dev Biol 10:864022, 2022. PMC9092217. DOI: 10.3389/fcell.2022.864022\n\nSchaffert J, LoBue C, Hynan LS, Hart J, Rossetti H, Carlew AR, Lacritz L, White CL, Cullum CM. Predictors of Life Expectancy in Autopsy-Confirmed Alzheimer's Disease. Journal of Alzheimer's Disease 86:271-281, 2022. PMC8966055. DOI: 10.3233/JAD-215200\n\nShinto LH, Raber J, Mishra A, Roese N, Silbert LC. A Review of Oxylipins in Alzheimer's Disease and Related Dementias (ADRD): Potential Therapeutic Targets for the Modulation of Vascular Tone and Inflammation. Metabolites 12:826, 2022. PMC9501361. DOI: 10.3390/metabo12090826\n\nSternberg Z, Podolsky R, Nir A, Yu J, Nir R, Halvorsen SW, Quinn JF, Kaye J, Kolb C. Elevated spermidine serum levels in mild cognitive impairment, a potential biomarker of progression to Alzheimer dementia, a pilot study. J Clin Neurosci 100:169-174, 2022. DOI: 10.1016/j.jocn.2022.04.028\n\nTahami Monfared AA, Lenderking WR, Savva Y, Ladd MK, Zhang Q, Alzheimer’s Disease Neuroimaging Initiative. Assessing the Clinical Meaningfulness of the Alzheimer's Disease Composite Score (ADCOMS) Tool. Neurol Ther, 2022. DOI: 10.1007/s40120-022-00352-w\n\nTang F, Chen J, Dodge HH, Zhou J. The Joint Effects of Acoustic and Linguistic Markers for Early Identification of Mild Cognitive Impairment. Front Digit Health 3:702772, 2022. PMC8878676. DOI: 10.3389/fdgth.2021.702772\n\nTeng E, Manser PT, Pickthorn K, Brunstein F, Blendstrup M, Sanabria Bohorquez S, Wildsmith KR, Toth B, Dolton M, Ramakrishnan V, Bobbala A, Sikkes SAM, Ward M, Fuji RN, Kerchner GA, Tauriel Investigators. Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial. JAMA Neurol 79:758-767, 2022. PMC9194753. DOI: 10.1001/jamaneurol.2022.1375\n\nThomas N, Bhati D, Ault L, BEng L, Lariviere-Chartier J, Petriu M, Beng W, Knoefel F, Kaye J, Goubran R. Smart Home Tech: an interface to provide feedback to caregivers of persons living with cognitive impairment. Alzheimer & Dementia 18:2:e067374, 2022.\n\nTian C, Stewart T, Hong Z, Guo Z, Aro P, Soltys D, Pan C, Peskind ER, Zabetian CP, Shaw LM, Galasko D, Quinn JF, Shi M, Zhang J, Alzheimer's Disease Neuroimaging Initiative. Blood extracellular vesicles carrying synaptic function- and brain-related proteins as potential biomarkers for Alzheimer's disease. Alzheimers Dement, 2022. DOI: 10.1002/alz.12723\n\nTran L, Nunnerley M, Gothard S, Golonka O, Pierce A, Lindauer A. An Analysis of Factors Influencing Dementia Study Enrollment: Focus Groups with Diverse Community Members Viewing the ACTNOW Research Registry Website. Alzheimers Dement 18 Suppl 2:e064247, 2022.\n\nWang H, Kirby R, Pierce A, Barbaro M, Ho AF, Blalock J, Schrader CD. Patient Portal Use Among Diabetic Patients With Different Races and Ethnicities. J Clin Med Res 14:400-408, 2022. PMC9635808. DOI: 10.14740/jocmr4822\n\nWang M, Greenberg M, Forkert ND, Chekouo T, Afriyie G, Ismail Z, Smith EE, Sajobi TT. Dementia risk prediction in individuals with mild cognitive impairment: a comparison of Cox regression and machine learning models. BMC Med Res Methodol 22:284, 2022. PMC9628121. DOI: 10.1186/s12874-022-01754-y\n\nWeintraub S, Karpouzian-Rogers T, Peipert JD, Nowinski C, Slotkin J, Wortman K, Ho E, Rogalski E, Carlsson C, Giordani B, Goldstein F, Lucas J, Manly JJ, Rentz D, Salmon D, Snitz B, Dodge HH, Riley M, Eldes F, Ustsinovich V, Gershon R. ARMADA: Assessing reliable measurement in Alzheimer's disease and cognitive aging project methods. Alzheimers Dement 18:1449-1460, 2022. PMC9110564. DOI: 10.1002/alz.12497\n\nWen J, Fu CHY, Tosun D, Veturi Y, Yang Z, Abdulkadir A, Mamourian E, Srinivasan D, Skampardoni I, Singh A, Nawani H, Bao J, Erus G, Shou H, Habes M, Doshi J, Varol E, Mackin RS, Sotiras A, Fan Y, Saykin AJ, Sheline YI, Shen L, Ritchie MD, Wolk DA, Albert M, Resnick SM, Davatzikos C, iSTAGING Consortium, Alzheimer’s Disease Neuroimaging Initiative. Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression. JAMA Psychiatry 79:464-474, 2022. PMC8908227. DOI: 10.1001/jamapsychiatry.2022.0020\n\nWeston LJ, Bowman AM, Osterberg VR, Meshul CK, Woltjer RL, Unni VK. Aggregated Alpha-Synuclein Inclusions within the Nucleus Predict Impending Neuronal Cell Death in a Mouse Model of Parkinsonism. International Journal of Molecular Sciences 23, 2022. PMC9736441. DOI: 10.3390/ijms232315294\n\nWild K, Marcoe J, Mattek N, Sharma N, Loewy E, Tischler H, Kaye J, Karlawish J. Online monitoring of financial capacity in older adults: Feasibility and initial findings. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 14:e12282, 2022. PMC8911546. DOI: 10.1002/dad2.12282\n\nWilson EN, Young CB, Ramos Benitez J, Swarovski MS, Feinstein I, Vandijck M, Le Guen Y, Kasireddy NM, Shahid M, Corso NK, Wang Q, Kennedy G, Trelle AN, Lind B, Channappa D, Belnap M, Ramirez V, Skylar-Scott I, Younes K, Yutsis MV, Le Bastard N, Quinn JF, van Dyck CH, Nairn A, Fredericks CA, Tian L, Kerchner GA, Montine TJ, Sha SJ, Davidzon G, Henderson VW, Longo FM, Greicius MD, Wagner AD, Wyss-Coray T, Poston KL, Mormino EC, Andreasson KI. Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's disease. Alzheimers Res Ther 14:172, 2022. PMC9652927. DOI: 10.1186/s13195-022-01116-2\n\nWinter S, Angler D, Dawson W, Bennett V, Lee C, Freeman M, Hynes W, Berk M, Sarnyai Z, Ng C, Abbott R, Ibañez A, Smith E, Hackett J, Storch E, Jraissati J, Corner L, Chen S, Carlo A, Bilder R, Moutier C, Soares J, Ayadi R, Santuccione C, Manes F, Rommelfanger K, Oertel W, Jeste D, Destrebecq F, Robertson I, D’Esposito M, Matthews M, Graham C, Eyre H. Brain health-Directed Policymaking: A New Concept to Strengthen Democracy. Washington, DC., 2022\n\nWright KM, Bollen M, David J, Speers AB, Brandes MS, Gray NE, Alcazar Magana A, McClure C, Stevens JF, Maier CS, Quinn JF, Soumyanath A. Pharmacokinetics and Pharmacodynamics of Key Components of a Standardized Centella asiatica Product in Cognitively Impaired Older Adults: A Phase 1, Double-Blind, Randomized Clinical Trial. Antioxidants (Basel) 11, 2022. PMC8868383. DOI: 10.3390/antiox11020215\n\nWu CY, Dodge HH, Gothard S, Mattek N, Wright K, Barnes LL, Silbert LC, Lim MM, Kaye JA, Beattie Z. Unobtrusive Sensing Technology Detects Ecologically Valid Spatiotemporal Patterns of Daily Routines Distinctive to Persons with Mild Cognitive Impairment. J Gerontol A Biol Sci Med Sci, 2022. PMC9536445. DOI: 10.1093/gerona/glab293\n\nWu CY, Mattek N, Wild K, Miller LM, Kaye JA, Silbert LC, Dodge HH. Can changes in social contact (frequency and mode) mitigate low mood before and during the COVID-19 pandemic? The I-CONECT project. Journal of the American Geriatrics Society 70:669-676, 2022. PMC8904274. DOI: 10.1111/jgs.17607\n\nYan T, Liang J, Gao J, Wang L, Fujioka H, Zhu X, Wang X, Alzheimer Disease Neuroimaging Initiative. FAM222A encodes a protein which accumulates in plaques in Alzheimer's disease. Nat Commun 11:4006, 2022. DOI: 10.1038/s41467-019-13962-0\n\nYang Z, Caldwell JZK, Cummings JL, Ritter A, Kinney JW, Cordes D, Alzheimer's Disease Neuroimaging Initiative. Sex Modulates the Pathological Aging Effect on Caudate Functional Connectivity in Mild Cognitive Impairment. Front Psychiatry 13:804168, 2022. PMC9037326. DOI: 10.3389/fpsyt.2022.804168\n\nYildiz S, Grinstead J, Hildebrand A, Oshinski J, Rooney WD, Lim MM, Oken B. Immediate impact of yogic breathing on pulsatile cerebrospinal fluid dynamics. Sci Rep 12:10894, 2022. PMC9240010. DOI: 10.1038/s41598-022-15034-8\n\nYu K, Wild K, Dowling M, Kaye J, Silbert L, Dodge H. Emotional Characteristics of Socially Isolated Older Adults with MCI Using Tablet Administered NIH Toolbox: I-CONECT study. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 14:e12372, 2022. PMC9652485. DOI: 10.1002/dad2.12372\n\nAhn, S., Mathiason, M. A., Salisbury, D., & Yu, F. (2020). Factors Predicting the Onset of Amnestic Mild Cognitive Impairment or Alzheimer's Dementia in Persons With Subjective Cognitive Decline. Journal of gerontological nursing, 46(8), 28–36. https://doi.org/10.3928/00989134-20200619-01\n\nAn, N., Ding, H., Yang, J., Au, R., & Ang, T. (2020). Deep ensemble learning for Alzheimer's disease classification. Journal of biomedical informatics, 105, 103411. https://doi.org/10.1016/j.jbi.2020.103411\n\nAnderson VC, Tagge IJ, Li X, et al. (2020.) Observation of Reduced Homeostatic Metabolic Activity and/or Coupling in White Matter Aging. Journal of Neuroimaging: Official Journal of the American Society of Neuroimaging. Sep;30(5):658-665.\n\nAnstey, Kaarin J. et al. (2020.) Future Directions for Dementia Risk Reduction and Prevention Research: An International Research Network on Dementia Prevention Consensus. Journal of Alzheimer’s Disease. Vol. Pre-Press. 1 Jan. : 1 – 10.\n\nAsgari, M., Gale, R., Wild, K., Dodgeb, H., & Kaye, J. (2020). Automatic Assessment of Cognitive Tests for Differentiating Mild Cognitive Impairment: A Proof of Concept Study of the Digit Span Task. Current Alzheimer research, 10.2174/1567205017666201008110854.\n\nAu-Yeung, W.T.M., Kaye, J., & Beattie, Z. (2020.) Step Count Standardization: Validation of Step Counts from the Withings Activite using PiezoRxD and wGT3X-BT. 2020 42nd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC), Montreal, QC, Canada, 2020, pp. 4608-4611.\n\nAu-Yeung, W. M., Miller, L., Beattie, Z., Dodge, H. H., Reynolds, C., Vahia, I., & Kaye, J. (2020). Sensing a problem: Proof of concept for characterizing and predicting agitation. Alzheimer's & dementia (New York, N. Y.), 6(1), e12079.\n\nAtayde, A. L., Fischer, C. E., Schweizer, T. A., & Munoz, D. G. (2020). Neuropsychiatric Inventory-Assessed Nighttime Behavior Accompanies, but Does Not Precede, Progressive Cognitive Decline Independent of Alzheimer's Disease Histopathology. Journal of Alzheimer's disease : JAD, 74(3), 839–850. https://doi.org/10.3233/JAD-190907\n\nBeattie Z, Miller L, Almirola C, Au-Yeung W, Bernard H, Cosgrove K, Dodge H, Gamboa C, Golonka O, Gothard S, Harbison S, Irish S, Kornfeld J, Lee J, Marcoe J, Mattek N, Quinn C, Reynolds C, Riley T, Rodrigues N, Sharma N, Siqueland M, Thomas N, Truty T, Wall R, Wild K, Wu C, Karlawish J, Silverberg N, Barnes L, Czaja S, Silbert L, Kaye K. (2020.) The Collaborative Aging Research using Technology (CART) Initiative: An open, sharable, technology-agnostic platform for the research community Digital Biomarkers, Forthcoming.\n\nBissig, D., Kaye, J., & Erten-Lyons, D. (2020). Validation of SATURN, a free, electronic, self-administered cognitive screening test. Alzheimer's & dementia (New York, N. Y.), 6(1), e12116. https://doi.org/10.1002/trc2.12116\n\nBissig, D., Zhou, C. G., Le, V., & Bernard, J. T. (2020). Optical coherence tomography reveals light-dependent retinal responses in Alzheimer's disease. NeuroImage, 219, 117022.\n\nBlanken, A. E., Jang, J. Y., Ho, J. K., Edmonds, E. C., Han, S. D., Bangen, K. J., & Nation, D. A. (2020). Distilling Heterogeneity of Mild Cognitive Impairment in the National Alzheimer Coordinating Center Database Using Latent Profile Analysis. JAMA network open, 3(3), e200413.\n\nBoggess, M. B., Barber, J. M., Jicha, G. A., & Caban-Holt, A. (2020). Subjective Memory Complaints Are an Important Surrogate for Objective Cognitive Performance in African Americans. Alzheimer disease and associated disorders, 34(1), 79–84. https://doi.org/10.1097/WAD.0000000000000348\n\nBonds K., Song M., Whitlatch CJ., et al. (2020.) Patterns of Dyadic Appraisal of Decision-Making Involvement of African American Persons Living with Dementia. The Gerontologist. Jul. DOI: 10.1093/geront/gnaa086.\n\nBolton, C. J., & Tam, J. W. (2020). Differential Involvement of the Locus Coeruleus in Early- and Late-Onset Alzheimer's Disease: A Potential Mechanism of Clinical Differences?. medRxiv : the preprint server for health sciences, 2020.11.01.20224139. https://doi.org/10.1101/2020.11.01.20224139\n\nBrenowitz, W. D., Besser, L. M., Kukull, W. A., Keene, C. D., Glymour, M. M., & Yaffe, K. (2020). Clinician-judged hearing impairment and associations with neuropathologic burden. Neurology, 95(12), e1640–e1649. https://doi.org/10.1212/WNL.0000000000010575\n\nCerino, E. S., Hooker, K., Goodrich, E., & Dodge, H. H. (2020). Personality Moderates Intervention Effects on Cognitive Function: A 6-Week Conversation-Based Intervention. The Gerontologist, 60(5), 958–967. https://doi.org/10.1093/geront/gnz063\n\nChen, L., Dodge, H. H., & Asgari, M. (2020). Topic-Based Measures of Conversation for Detecting Mild Cognitive Impairment. Proceedings of the conference. Association for Computational Linguistics. Meeting, 2020, 63–67.\n\nChen, L., Asgari, M., Gale, R., Wild, K., Dodge, H., Kaye, J. Improving the assessment of Mild Cognitive Impairment in advanced age with a novel multi-feature automated speech and language analysis of verbal fluency. Frontiers in Psychology: Psychology for Clinical Settings. 2020. doi: 10.3389/fpsyg.2020.00535\n\nCroff, R., Gowen, L. K., Lindauer, A., Shofner, S., Brown, K., & Eckstrom, E. (2020). Including older rural adults in research: Practical guidance for addressing the NIH Inclusion Across the Lifespan policy. Journal of clinical and translational science, 4(5), 431–436. https://doi.org/10.1017/cts.2020.12\n\nCroff, R., Tang, W., Friedman, D. B., Balbim, G. M., & Belza, B. (2020). Training the next generation of aging and cognitive health researchers. Gerontology & geriatrics education, 1–17. Advance online publication. https://doi.org/10.1080/02701960.2020.1824912\n\nCulhane, J. E., Chan, K., Teylan, M. A., Chen, Y. C., Mock, C., Gauthreaux, K., & Kukull, W. A. (2020). Factor Consistency of Neuropsychological Test Battery Versions in the NACC Uniform Data Set. Alzheimer disease and associated disorders, 34(2), 175–177. https://doi.org/10.1097/WAD.0000000000000376\n\nDai, D. L., Tropea, T. F., Robinson, J. L., Suh, E., Hurtig, H., Weintraub, D., Van Deerlin, V., Lee, E. B., Trojanowski, J. Q., & Chen-Plotkin, A. S. (2020). ADNC-RS, a clinical-genetic risk score, predicts Alzheimer's pathology in autopsy-confirmed Parkinson's disease and Dementia with Lewy bodies. Acta neuropathologica, 140(4), 449–461. https://doi.org/10.1007/s00401-020-02199-7\n\nDawson, W. D., Bobrow, K., Ibanez, A., Booi, L., Pintado-Caipa, M., Yamamoto, S., Tarnanas, I., Evans, T., Comas-Herrera, A., Cummings, J., Kaye, J., Yaffe, K., Miller, B. L., & Eyre, H. A. (2020). The necessity of diplomacy in brain health. The Lancet. Neurology, 19(12), 972–974. https://doi.org/10.1016/S1474-4422(20)30358-6\n\nDenny, A., Streitz, M., Stock, K., Balls-Berry, J. E., Barnes, L. L., Byrd, G. S., Croff, R., Gao, S., Glover, C. M., Hendrie, H. C., Hu, W. T., Manly, J. J., Moulder, K. L., Stark, S., Thomas, S. B., Whitmer, R., Wong, R., Morris, J. C., & Lingler, J. H. (2020). Perspective on the \"African American participation in Alzheimer disease research: Effective strategies\" workshop, 2018. Alzheimer's & dementia : the journal of the Alzheimer's Association, 16(12), 1734–1744. https://doi.org/10.1002/alz.12160\n\nDodge, H. H., Goldstein, F. C., Wakim, N. I., Gefen, T., Teylan, M., Chan, K., Kukull, W. A., Barnes, L. L., Giordani, B., Hughes, T. M., Kramer, J. H., Loewenstein, D. A., Marson, D. C., Mungas, D. M., Mattek, N., Sachs, B. C., Salmon, D. P., Willis-Parker, M., Welsh-Bohmer, K. A., Wild, K. V., … National Alzheimer's Coordinating Center (NACC) (2020). Differentiating among stages of cognitive impairment in aging: Version 3 of the Uniform Data Set (UDS) neuropsychological test battery and MoCA index scores. Alzheimer's & dementia (New York, N. Y.), 6(1), e12103. https://doi.org/10.1002/trc2.12103\n\nFowe I. (2020.) One-Year, Weekly Online Survey to Monitor Healthcare Visits and its Association With Walking-Speed in Older Adults. In: AMIA 2020 Informatics Conference Online meeting, Forthcoming.\n\nFranzmeier, N., Suárez-Calvet, M., Frontzkowski, L., Moore, A., Hohman, T. J., Morenas-Rodriguez, E., Nuscher, B., Shaw, L., Trojanowski, J. Q., Dichgans, M., Kleinberger, G., Haass, C., Ewers, M., & Alzheimer’s Disease Neuroimaging Initiative (ADNI) (2020). Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration. Molecular neurodegeneration, 15(1), 57. https://doi.org/10.1186/s13024-020-00407-2\n\nGefen, T., Teylan, M. A., Besser, L., Pollner, E., Moshkovich, A., & Weintraub, S. (2020). Measurement and characterization of distinctive clinical phenotypes using the Frontotemporal Lobar Degeneration Module (FTLD-MOD). Alzheimer's & dementia : the journal of the Alzheimer's Association, 16(6), 918–925.\n\nGoldberg, T.E., Huey, E.D. & Devanand, D.P. (2020). Association of APOE e2 genotype with Alzheimer’s and non-Alzheimer’s neurodegenerative pathologies. Nature Communications. 11, 4727.\n\nGrasby, K. L., Jahanshad, N., Painter, J. N., Colodro-Conde, L., Bralten, J., Hibar, D. P., Lind, P. A., Pizzagalli, F., et al. (2020.) Enhancing NeuroImaging Genetics through Meta-Analysis Consortium (ENIGMA)—Genetics working group. The genetic architecture of the human cerebral cortex. Science (New York, N.Y.), 367(6484), eaay6690.\n\nGold, D., Rosowsky, E., Piryatinsky, I., & Sinclair, S. J. (2020). Comparing patient and informant ratings of depressive symptoms in various stages of Alzheimer's disease. Neuropsychology, 34(5), 535–550. https://doi.org/10.1037/neu0000630\n\nHowarth, C., Mishra, A., & Hall, C. N. (2021). More than just summed neuronal activity: how multiple cell types shape the BOLD response. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 376(1815), 20190630. https://doi.org/10.1098/rstb.2019.0630\n\nJohn, S. E., Evans, S. A., Hanfelt, J., Loring, D. W., & Goldstein, F. C. (2020). Subjective Memory Complaints in White and African American Participants. Journal of geriatric psychiatry and neurology, 33(3), 135–143. https://doi.org/10.1177/0891988719868305\n\nKabacińska, K., Sharma, N., Kaye, J., Mattek, N., Kuzeljevic, B., & Robillard, J. Investigating the concept of participant burden in aging technology research. BMC Geriatrics. 2020. 20(50).\n\nKaur, D., Bucholc, M., Finn, D. P., Todd, S., Wong-Lin, K., & McClean, P. L. (2020). Multi-time-point data preparation robustly reveals MCI and dementia risk factors. Alzheimer's & dementia (Amsterdam, Netherlands), 12(1), e12116. https://doi.org/10.1002/dad2.12116\n\nKhan, T., & Jacobs, P. (2020). Prediction of mild cognitive impairment using movement complexity. IEEE journal of biomedical and health informatics, 10.1109/JBHI.2020.2985907. Advance online publication.\n\nKurasz, A. M., Smith, G. E., McFarland, M. G., & Armstrong, M. J. (2020). Ethnoracial Differences in Lewy Body Diseases with Cognitive Impairment. Journal of Alzheimer's disease : JAD, 77(1), 165–174. https://doi.org/10.3233/JAD-200395\n\nKunkle, B. W., Schmidt, M., Klein, H. U., Naj, A. C., Hamilton-Nelson, K. L., Larson, E. B., Evans, D. A., De Jager, P. L., Crane, P. K., et al. (2020). Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. JAMA neurology, e203536. Advance online publication.\n\nKiselica, A. M., Webber, T. A., & Benge, J. F. (2020). The Uniform Dataset 3.0 Neuropsychological Battery: Factor Structure, Invariance Testing, and Demographically Adjusted Factor Score Calculation. Journal of the International Neuropsychological Society : JINS, 26(6), 576–586. https://doi.org/10.1017/S135561772000003X\n\nLedger, C., Karameh, W. K., Munoz, D. G., Fischer, C. E., & Schweizer, T. A. (2020). Gender role in sleep disturbances among older adults with traumatic brain injury. International review of psychiatry (Abingdon, England), 32(1), 39–45. https://doi.org/10.1080/09540261.2019.1657384\n\nLiew, T.M. Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer’s and non-Alzheimer’s dementia. Alz Res Therapy 12, 35 (2020). https://doi.org/10.1186/s13195-020-00604-7\n\nLiew T. M. (2020). Active case finding of dementia in ambulatory care settings: a comparison of three strategies. European journal of neurology, 27(10), 1867–1878. https://doi.org/10.1111/ene.14353\n\nLindauer, A., Wild, K., Natonson, A., Mattek, N., Wolf, M., Steeves-Reece, A., & Messecar, D. (2020). Dementia 360 ECHO: Using technology to facilitate diagnosis and treatment. Gerontology & geriatrics education, 1–7. Advance online publication. https://doi.org/10.1080/02701960.2020.1835658\n\nLoBue C, Schaffert J, Cullum CM, Peters ME, Didehbani N, Hart J, White CL. Clinical and neuropsychological profile of patients with dementia and chronic traumatic encephalopathy. J Neurol Neurosurg Psychiatry 91:586-592, 2020. PMC7231625\n\nMarawar, R., Wakim, N., Albin, R. L., & Dodge, H. (2020). Seizure occurrence and related mortality in dementia with Lewy bodies. Epilepsy & behavior: E&B, 111, 107311.\n\nMartinez, A. I., Abner, E. L., Jicha, G. A., Rigsby, D. N., Eckmann, L. C., Huffmyer, M. J., & Moga, D. C. (2020). One-Year Evaluation of a Targeted Medication Therapy Management Intervention for Older Adults. Journal of managed care & specialty pharmacy, 26(4), 520–528. https://doi.org/10.18553/jmcp.2020.26.4.520\n\nMatthews, D. G., Caruso, M., Alcazar Magana, A., Wright, K. M., Maier, C. S., Stevens, J. F., Gray, N. E., Quinn, J. F., & Soumyanath, A. (2020). Caffeoylquinic Acids in Centella asiatica Reverse Cognitive Deficits in Male 5XFAD Alzheimer's Disease Model Mice. Nutrients, 12(11), 3488. https://doi.org/10.3390/nu12113488\n\nMoniruzzaman M, Kadota A, Akash M, Pruitt P, Miura K, Albin R, Dodge H. (2020.) Effects of physical activities on dementia-related biomarkers: a systematic review of randomized controlled trials. Alzheimer's & Dementia: Translational Research & Clinical Interventions. Forthcoming.\n\nMoloney, M., Oh, G., & Moga, D. C. (2020). Determinants of Sleep Medication Use among Participants in the National Alzheimer's Coordinating Center Uniform Data Set. Journal of applied gerontology : the official journal of the Southern Gerontological Society, 39(12), 1340–1349. https://doi.org/10.1177/0733464819888447\n\nOrdaz-Johnson, O. H., Croff, R. L., Robinson, L. D., Shea, S. A., & Bowles, N. P. (2020). More Than a Statistic: a Qualitative Study of COVID-19 Treatment and Prevention Optimization for Black Americans. Journal of general internal medicine, 35(12), 3750–3752. https://doi.org/10.1007/s11606-020-06259-2\n\nPelcher, I., Puzo, C., Tripodis, Y., Aparicio, H. J., Steinberg, E. G., Phelps, A., Martin, B., Palmisano, J. N., Vassey, E., Lindbergh, C., McKee, A. C., Stein, T. D., Killiany, R. J., Au, R., Kowall, N. W., Stern, R. A., Mez, J., & Alosco, M. L. (2020). Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures. Journal of Alzheimer's disease : JAD, 78(4), 1393–1408. https://doi.org/10.3233/JAD-200803\n\nPiantino, J., Boespflug, E. L., Schwartz, D. L., Luther, M., Morales, A. M., Lin, A., Fossen, R. V., Silbert, L., & Nagel, B. J. (2020). Characterization of MR Imaging-Visible Perivascular Spaces in the White Matter of Healthy Adolescents at 3T. AJNR. American journal of neuroradiology, 41(11), 2139–2145. https://doi.org/10.3174/ajnr.A6789\n\nPiau, A., Mattek, N., Crisse"
    }
}